Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,7.930671567467219e-39,20.918095238095237,1835.1461876743788,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",4.108087871948019e-36,0,0,68
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,6.637343241702726e-13,5.194103194103194,145.64729937477026,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",1.719071899601006e-10,0,0,42
3,Cholesterol Biosynthesis Pathway WP197,6.54717042660862e-08,21.495016611295682,355.56299388625337,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'CYP51A1', 'SC5D', 'MSMO1', 'MVD', 'HMGCR', 'DHCR7', 'LSS', 'FDFT1']",9.830419069994383e-06,0,0,12
4,Oxidative phosphorylation WP623,8.974783018786294e-08,4.981733985078467,80.83492078669246,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'NDUFB4', 'ATP6AP2', 'ATP5MC2', 'NDUFB2', 'NDUFC2', 'ATP5MC3', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",9.830419069994383e-06,0,0,24
5,Nonalcoholic fatty liver disease WP4396,9.488821496133575e-08,2.9527331075057943,47.747366548450636,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'ADIPOR1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'BBC3', 'LEPR', 'MLX', 'UQCRFS1', 'CYC1', 'XBP1', 'JUN', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",9.830419069994383e-06,0,0,43
6,Mitochondrial CIV Assembly WP4922,1.1948385777661886e-06,6.621702381968753,90.30346267872355,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",0.00010315439721381427,0,0,16
7,"GPCRs, Class A Rhodopsin-like WP455",8.294902003284056e-06,3.9003511599792757,45.63359937444577,"['GPR27', 'OPRD1', 'P2RY12', 'PTGFR', 'GPR12', 'HTR1F', 'P2RY14', 'CHRM5', 'F2R', 'GPR85', 'HTR2C', 'OPRK1', 'ADRA1D', 'NMBR', 'HTR4', 'HTR5A', 'MCHR1', 'HCRTR2', 'HRH1', 'HTR7', 'MC1R']",0.0006138227482430201,0,0,21
8,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,2.619430160763846e-05,4.035,42.56912357031424,"['IDI1', 'HMGCS1', 'CYP51A1', 'MSMO1', 'DHCR24', 'HMGCR', 'LSS', 'TM7SF2', 'SQLE', 'NSDHL', 'EBP', 'SCD', 'FASN', 'ACOT2', 'SC5D', 'MVD', 'DHCR7', 'FDFT1']",0.0016960810290945901,0,0,18
9,Mitochondrial complex I assembly model OXPHOS system WP4324,8.326174035751798e-05,3.4071150639244023,32.004808312020444,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'TMEM70', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.004792175722799368,0,0,19
10,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,9.260946090913423e-05,32.14238410596027,298.510154231979,"['NSDHL', 'EBP', 'CYP51A1', 'SC5D', 'DHCR24', 'DHCR7']",0.004797170075093153,0,0,6
11,Mitochondrial complex III assembly WP4921,0.0008547538755919518,6.125335438042621,43.27363886418061,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.04025113705060282,0,0,8
12,Selenium Micronutrient Network WP15,0.0009414508148084471,3.2678588643593947,22.770729617272416,"['GPX4', 'PLAT', 'KMO', 'SELENOK', 'SELENOH', 'SELENOM', 'SELENOS', 'FLAD1', 'RFK', 'SELENOW', 'PNPO', 'SELENOT', 'SEPHS2', 'LDLR']",0.04063929350589796,0,0,14
13,Senescence and Autophagy in Cancer WP615,0.0016284658426658268,2.3518363939899833,15.09906459835072,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CEBPB', 'TGFB1', 'CDKN1B', 'PCNA', 'IGFBP5', 'CDKN2A', 'FN1', 'PLAT', 'IGF1', 'CXCL14', 'GABARAP', 'RSL1D1', 'MAP1LC3B', 'MAP1LC3A', 'IGFBP7', 'IL6ST', 'HRAS', 'SLC39A3']",0.0648881005000691,0,0,21
14,Monoamine GPCRs WP58,0.002402410277043014,4.76316758747698,28.72801056992067,"['HRH1', 'HTR7', 'HTR1F', 'CHRM5', 'HTR2C', 'ADRA1D', 'HTR4', 'HTR5A']",0.08888918025059153,0,0,8
15,miR-517 relationship with ARCN1 and USP1 WP3596,0.003918641116268568,inf,inf,"['ID2', 'USP1', 'ARCN1']",0.13532373988180788,0,0,3
16,Ferroptosis WP4313,0.004340263167523976,3.1042728570180294,16.886686488917057,"['PRNP', 'MAP1LC3B', 'MAP1LC3A', 'GPX4', 'PCBP1', 'GSS', 'VDAC3', 'VDAC2', 'SAT2', 'SLC7A11', 'FTL']",0.14051602004858874,0,0,11
17,Proximal tubule transport WP4917,0.005940680732406013,3.152980218636127,16.16196078162489,"['ATP6V1G1', 'ABCB1', 'CA4', 'SLC3A1', 'ATP1A1', 'ATP6V1E1', 'ATP1B1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.18101603643448907,0,0,10
18,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.007005367166727145,6.690568119139548,33.19243489052809,"['SFRP1', 'SST', 'SMAD9', 'DCN', 'FOXO1']",0.20159889957581453,0,0,5
19,Cardiac Progenitor Differentiation WP2406,0.008012434070085119,3.5712707182320442,17.237669098795955,"['MESP1', 'LIN28B', 'TGFB1', 'TNNT2', 'KIT', 'ROR2', 'THY1', 'IGF1']",0.2109391068381701,0,0,8
20,Allograft Rejection WP2328,0.008144367059388808,3.2149253731343284,15.465169440964795,"['ABCB1', 'TGFB1', 'COL5A1', 'HLA-B', 'HLA-C', 'HLA-A', 'VIM', 'HLA-F', 'VEGFA']",0.2109391068381701,0,0,9
21,Endochondral Ossification with Skeletal Dysplasias WP4808,0.01027556581107201,2.403801700257904,11.004571620308266,"['TGFB1', 'HMGCS1', 'PLAT', 'IGF1', 'GLI3', 'RUNX2', 'PTHLH', 'VEGFA', 'GHR', 'ADAMTS5', 'TIMP3', 'SOX6', 'FGFR3']",0.2419428677334228,0,0,13
22,Endochondral Ossification WP474,0.01027556581107201,2.403801700257904,11.004571620308266,"['TGFB1', 'HMGCS1', 'PLAT', 'IGF1', 'GLI3', 'RUNX2', 'PTHLH', 'VEGFA', 'GHR', 'ADAMTS5', 'TIMP3', 'SOX6', 'FGFR3']",0.2419428677334228,0,0,13
23,ACE Inhibitor Pathway WP554,0.01382294492606899,16.044628099173554,68.69387814469913,"['TGFB1', 'ATP6AP2', 'AGT']",0.2914638226592491,0,0,3
24,Mevalonate pathway WP3963,0.014462694141372566,7.133406835722161,30.218415077351843,"['HMGCS1', 'MVD', 'HMGCR', 'ACAT2']",0.2914638226592491,0,0,4
25,Imatinib and Chronic Myeloid Leukemia WP3640,0.01462945828019397,4.014900662251655,16.961823467995018,"['SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'KIT', 'PIM1']",0.2914638226592491,0,0,6
26,Peptide GPCRs WP24,0.01462945828019397,4.014900662251655,16.961823467995018,"['OPRD1', 'MC1R', 'OPRK1', 'NMBR', 'ACKR1', 'HCRTR2']",0.2914638226592491,0,0,6
27,Aryl Hydrocarbon Receptor Pathway WP2873,0.015193763693576352,3.060457774269929,12.813739510485254,"['SLC7A5', 'HSP90AA1', 'JUN', 'CDKN1B', 'TGFB1', 'AIP', 'BAX', 'JUNB']",0.29149517012120557,0,0,8
28,Nuclear Receptors Meta-Pathway WP2882,0.01635996767267329,1.5426530692190172,6.344805458607476,"['ABCB1', 'CDKN1B', 'SRXN1', 'GSTP1', 'SLC7A11', 'SLC6A1', 'SLC5A3', 'CYP3A5', 'SLC5A4', 'FOXO1', 'RGS2', 'SLC39A6', 'SLC39A7', 'JUNB', 'CBR3', 'SLC39A3', 'JUN', 'HSP90AA1', 'TGFB1', 'PLK2', 'HGF', 'SLC2A12', 'SLC39A11', 'AIP', 'SLC39A13', 'CES4A', 'SLC2A9', 'TGFBR3', 'SLC7A5', 'PSMC5', 'SCD', 'FASN', 'B3GNT5', 'BAX', 'MFGE8', 'FKBP5', 'FTL']",0.3026594019444559,0,0,37
29,NOTCH1 regulation of endothelial cell calcification WP3413,0.019509161548290445,4.45945945945946,17.55631707093645,"['ITGA1', 'PLAT', 'SOX6', 'FGFR3', 'VEGFA']",0.3368581894004817,0,0,5
30,TP53 network WP1742,0.019509161548290445,4.45945945945946,17.55631707093645,"['SUMO1', 'CDKN2A', 'GADD45A', 'BAX', 'BBC3']",0.3368581894004817,0,0,5
31,NRF2 pathway WP2884,0.02461788380814127,1.7882156753752085,6.624055346018411,"['HSP90AA1', 'TGFB1', 'SRXN1', 'HGF', 'GSTP1', 'SLC2A12', 'SLC39A11', 'SLC39A13', 'SLC7A11', 'SLC6A1', 'SLC5A3', 'SLC5A4', 'CES4A', 'SLC2A9', 'SLC39A6', 'SLC39A7', 'SLC39A3', 'FTL', 'CBR3']",0.36474510481888245,0,0,19
32,Composition of Lipid Particles WP3601,0.02486717385845,inf,inf,"['APOE', 'LDLR']",0.36474510481888245,0,0,2
33,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.02486717385845,inf,inf,"['TGFB1', 'VIP']",0.36474510481888245,0,0,2
34,COVID-19 adverse outcome pathway WP4891,0.02486717385845,inf,inf,"['IL7', 'AGT']",0.36474510481888245,0,0,2
35,Gastric acid production WP2596,0.02486717385845,inf,inf,"['CCK', 'VIP']",0.36474510481888245,0,0,2
36,miR-509-3p alteration of YAP1/ECM axis WP3967,0.025349080643783335,5.349503858875414,19.659495241250614,"['COL5A1', 'PBX3', 'FN1', 'GPC6']",0.36474510481888245,0,0,4
37,miRNA targets in ECM and membrane receptors WP2911,0.029178639414237127,3.8219998424080055,13.508164231427665,"['COL5A1', 'COL5A3', 'ITGA1', 'COL5A2', 'FN1']",0.39775092675196927,0,0,5
38,Statin inhibition of cholesterol production WP430,0.029178639414237127,3.8219998424080055,13.508164231427665,"['SQLE', 'HMGCR', 'APOE', 'LDLR', 'FDFT1']",0.39775092675196927,0,0,5
39,7-oxo-C and 7beta-HC pathways WP5064,0.03963415612111259,2.919024683925346,9.422798509476449,"['EBP', 'DBP', 'EPHX2', 'ACOT11', 'ACOT2', 'DHCR7']",0.513262321768408,0,0,6
40,Differentiation Pathway WP2848,0.03963415612111259,2.919024683925346,9.422798509476449,"['TGFB1', 'HGF', 'KIT', 'IGF1', 'FGF1', 'VEGFA']",0.513262321768408,0,0,6
41,Development of ureteric collection system WP5053,0.04164817983014823,2.379373848987109,7.562834099157696,"['GDF11', 'SALL1', 'FRAS1', 'ANOS1', 'ETV4', 'GLI3', 'FGFR2', 'FREM2']",0.5261891988296776,0,0,8
42,Vitamin D Receptor Pathway WP2877,0.04268946134795932,1.7864669994453688,5.634165332486404,"['ABCB1', 'TGFB1', 'CDKN1B', 'IGFBP5', 'GADD45A', 'CDKN2A', 'CYP3A5', 'FOXO1', 'PTHLH', 'ADAMTS5', 'SFRP1', 'PNOC', 'TIMP2', 'TIMP3', 'JUNB']",0.5265033566248316,0,0,15
43,Oxysterols derived from cholesterol WP4545,0.04667090675942531,2.497736057426836,7.654647569054206,"['EBP', 'DBP', 'INSIG1', 'EPHX2', 'ACOT11', 'ACOT2', 'DHCR7']",0.5494438568495981,0,0,7
44,Photodynamic therapy-induced unfolded protein response WP3613,0.04667090675942531,2.497736057426836,7.654647569054206,"['PPP1R15A', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'BBC3']",0.5494438568495981,0,0,7
45,IL-18 signaling pathway WP4754,0.04979441716515057,1.431578947368421,4.2945255501477915,"['CEBPB', 'TOMM40', 'STOML1', 'EPB41', 'CD81', 'RGS16', 'ITGA2B', 'COX17', 'PLD1', 'ACACB', 'CENPB', 'ADAMTS5', 'TMSB4X', 'TIMP3', 'CD36', 'B2M', 'JUN', 'TICAM2', 'USP5', 'PRKCD', 'FN1', 'NDUFC1', 'BPGM', 'RUNX2', 'VEGFA', 'ARL4D', 'SYT10', 'RFX5', 'CYCS', 'BAX', 'ITM2C', 'ARF6']",0.5731890687010666,0,0,32
46,Biogenic Amine Synthesis WP550,0.05394338102941785,5.347107438016529,15.612592747196357,"['GAD1', 'PAH', 'GAD2']",0.5945249228348606,0,0,3
47,Cellular Proteostasis WP4918,0.05394338102941785,5.347107438016529,15.612592747196357,"['VBP1', 'PFDN5', 'PFDN6']",0.5945249228348606,0,0,3
48,Pregnane X receptor pathway WP2876,0.056271024962390934,2.9720536863394007,8.552308963516161,"['HSP90AA1', 'PSMC5', 'ABCB1', 'CYP3A5', 'FOXO1']",0.6072581443858022,0,0,5
49,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.0585694789653885,3.565600882028666,10.117540670765683,"['IDI1', 'HMGCS1', 'MVD', 'HMGCR']",0.6191630633483927,0,0,4
50,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.06556487413155952,1.9121365360303413,5.2100274493027845,"['BEX3', 'CDKN1B', 'HSPA5', 'RIPK2', 'F2R', 'PTK2B', 'RNF7', 'APOE', 'VIM', 'ETS1']",0.6781160669117594,0,0,10
51,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.06676432319015392,10.690528634361234,28.934839678829267,"['BAX', 'IL6ST']",0.6781160669117594,0,0,2
52,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.07381281021136057,2.674572531715389,6.970532400089936,"['HMGCS1', 'SCD', 'FASN', 'HMGCR', 'LDLR']",0.7352891478747072,0,0,5
53,BMP Signaling Pathway in Eyelid Development WP3927,0.08088968071554267,3.0559143172153096,7.684613058537106,"['JUN', 'SFRP1', 'DKK2', 'FGFR2']",0.785314762323696,0,0,4
54,Folate Metabolism WP176,0.08207803542265757,2.292809839167455,5.732219103294593,"['AHCY', 'GPX4', 'FLAD1', 'RFK', 'PLAT', 'LDLR']",0.785314762323696,0,0,6
55,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.08355392861619458,4.0099173553719005,9.953669499963548,"['GALNT3', 'FGFR3', 'FGFR2']",0.785314762323696,0,0,3
56,Oncostatin M Signaling Pathway WP2374,0.08489889322418336,1.6908550445882147,4.1701460266711265,"['CEBPB', 'CDKN1B', 'PRKCH', 'PRKCD', 'RPS6', 'TIMP3', 'PTK2B', 'IL6ST', 'JUNB', 'HRAS', 'LDLR', 'VEGFA']",0.785314762323696,0,0,12
57,Exercise-induced Circadian Regulation WP410,0.08793762708015908,1.7842920353982301,4.337841433484573,"['PER2', 'DNAJA1', 'IDI1', 'DAZAP2', 'CEBPB', 'SUMO1', 'RBPMS', 'GSTP1', 'EIF4G2', 'HERPUD1']",0.7991524706582879,0,0,10
58,Zinc homeostasis WP3529,0.0939659018131925,2.4311788597502884,5.749308436344496,"['SLC39A6', 'SLC39A11', 'SLC39A13', 'SLC39A7', 'SLC39A3']",0.8392127092971331,0,0,5
59,Lung fibrosis WP3624,0.10024708163253879,2.139735099337748,4.921641771007018,"['CEBPB', 'TGFB1', 'HGF', 'FAM13A', 'IGF1', 'FGF1']",0.8577246290392676,0,0,6
60,Nanomaterial induced apoptosis WP2507,0.10674521845424696,2.673649393605292,5.981783647403673,"['ENDOG', 'HTRA2', 'BAX', 'CYCS']",0.8577246290392676,0,0,4
61,Phytochemical activity on NRF2 transcriptional activation WP3,0.10674521845424696,2.673649393605292,5.981783647403673,"['AIMP2', 'CEBPB', 'SLC7A11', 'EPHB2']",0.8577246290392676,0,0,4
62,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.10674521845424696,2.673649393605292,5.981783647403673,"['DDR1', 'TGFB1', 'FN1', 'IGFBP7']",0.8577246290392676,0,0,4
63,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.10674521845424696,2.673649393605292,5.981783647403673,"['TGFB1', 'FN1', 'VIM', 'RUNX2']",0.8577246290392676,0,0,4
64,Galanin receptor pathway WP4970,0.11847686201412624,3.207603305785124,6.841938440241999,"['CDKN1B', 'PRKCD', 'VEGFA']",0.8577246290392676,0,0,3
65,Matrix Metalloproteinases WP129,0.11847686201412624,3.207603305785124,6.841938440241999,"['MMP16', 'TIMP2', 'TIMP3']",0.8577246290392676,0,0,3
66,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.11970575261365843,5.344713656387666,11.345323138080156,"['GSTP1', 'EPHX2']",0.8577246290392676,0,0,2
67,Cytokines and Inflammatory Response WP530,0.11970575261365843,5.344713656387666,11.345323138080156,"['TGFB1', 'IL7']",0.8577246290392676,0,0,2
68,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.11970575261365843,5.344713656387666,11.345323138080156,"['ID2', 'RUNX2']",0.8577246290392676,0,0,2
69,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.11970575261365843,5.344713656387666,11.345323138080156,"['FN1', 'VIM']",0.8577246290392676,0,0,2
70,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.11970575261365843,5.344713656387666,11.345323138080156,"['APOE', 'LDLR']",0.8577246290392676,0,0,2
71,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.11970575261365843,5.344713656387666,11.345323138080156,"['VEGFB', 'VEGFA']",0.8577246290392676,0,0,2
72,Somatic sex determination WP4814,0.11970575261365843,5.344713656387666,11.345323138080156,"['FGF9', 'PTGDS']",0.8577246290392676,0,0,2
73,Glycolysis and Gluconeogenesis WP534,0.12087625081055316,1.8723357261181668,3.9562228787473486,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'PGAM1', 'ALDOC', 'PFKM']",0.8577246290392676,0,0,7
74,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.13578798394726985,2.3763322307975008,4.744728821835624,"['OMG', 'IGF1', 'ASCL1', 'SOX6']",0.937842342462477,0,0,4
75,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.13578798394726985,2.3763322307975008,4.744728821835624,"['BAX', 'PTHLH', 'BCL2L14', 'BCL2L2']",0.937842342462477,0,0,4
76,"GPCRs, Other WP117",0.1404203959082169,1.7829928216454998,3.500219111384205,"['PTGFR', 'HTR7', 'ADGRV1', 'HTR1F', 'F2R', 'ADRA1D', 'ACKR1']",0.940000896654804,0,0,7
77,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.1415445365619203,2.056727056727057,4.021191117581641,"['LDHA', 'RPS6', 'PDHB', 'ACACB', 'VEGFA']",0.940000896654804,0,0,5
78,White fat cell differentiation WP4149,0.1415445365619203,2.056727056727057,4.021191117581641,"['TLE3', 'CEBPB', 'DDIT3', 'NR2F2', 'FOXO1']",0.940000896654804,0,0,5
79,Apoptosis Modulation and Signaling WP1772,0.1476398925014991,1.4934713744881403,2.8569795690545594,"['HRK', 'JUN', 'ENDOG', 'CDKN2A', 'PTRH2', 'HTRA2', 'CYCS', 'BAX', 'PRKD1', 'PTPN13', 'BCL2L2', 'BBC3']",0.9585248613520372,0,0,12
80,Alanine and aspartate metabolism WP106,0.15770327184042576,2.672727272727273,4.936634283339235,"['GOT1', 'GAD1', 'GAD2']",0.9585248613520372,0,0,3
81,Development and heterogeneity of the ILC family WP3893,0.15770327184042576,2.672727272727273,4.936634283339235,"['NFIL3', 'IL7', 'ID2']",0.9585248613520372,0,0,3
82,Genes targeted by miRNAs in adipocytes WP1992,0.15770327184042576,2.672727272727273,4.936634283339235,"['TMSB4X', 'IGF1', 'KCNJ2']",0.9585248613520372,0,0,3
83,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.15773009223073461,inf,inf,['FMO5'],0.9585248613520372,0,0,1
84,Codeine and Morphine Metabolism WP1604,0.15773009223073461,inf,inf,['ABCB1'],0.9585248613520372,0,0,1
85,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.15773009223073461,inf,inf,['AGT'],0.9585248613520372,0,0,1
86,Pyrimidine metabolism WP4022,0.16140463819875325,1.4137346776555244,2.578426966069991,"['NME2', 'NME3', 'NT5C', 'POLE4', 'NME6', 'POLE2', 'POLR1C', 'DPYD', 'TWISTNB', 'POLE3', 'POLR2E', 'POLR2I', 'POLR2K', 'POLR2L']",0.9585248613520372,0,0,14
87,Spinal Cord Injury WP2431,0.1625230403057987,1.4593778314708548,2.6515953910301175,"['TGFB1', 'CDKN1B', 'GADD45A', 'APEX1', 'CCNG1', 'OMG', 'XYLT1', 'AQP4', 'SLIT3', 'VIM', 'GFAP', 'TNFSF13B']",0.9585248613520372,0,0,12
88,Adipogenesis WP236,0.16699155827852924,1.3841872740834242,2.477435017034586,"['WWTR1', 'CEBPB', 'TGFB1', 'WNT5B', 'GADD45A', 'IGF1', 'FOXO1', 'AGT', 'LIPE', 'SFRP4', 'SCD', 'DDIT3', 'NDN', 'IL6ST', 'RXRG']",0.9585248613520372,0,0,15
89,DNA Mismatch Repair WP531,0.16855897023629882,1.9096209912536444,3.400022158133619,"['POLE4', 'PCNA', 'RPA3', 'POLE2', 'POLE3']",0.9585248613520372,0,0,5
90,Unfolded protein response WP4925,0.16855897023629882,1.9096209912536444,3.400022158133619,"['PPP1R15A', 'XBP1', 'HSPA5', 'DDIT3', 'BBC3']",0.9585248613520372,0,0,5
91,Dopaminergic Neurogenesis WP2855,0.17916877970038064,3.5627753303964758,6.125932148044084,"['TGFB1', 'ASCL1']",0.9585248613520372,0,0,2
92,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.17916877970038064,3.5627753303964758,6.125932148044084,"['CEBPB', 'ALDH1L1']",0.9585248613520372,0,0,2
93,Liver X receptor pathway WP2874,0.17916877970038064,3.5627753303964758,6.125932148044084,"['SCD', 'FASN']",0.9585248613520372,0,0,2
94,NAD Biosynthesis II (from tryptophan) WP2485,0.17916877970038064,3.5627753303964758,6.125932148044084,"['NMNAT1', 'KMO']",0.9585248613520372,0,0,2
95,Bladder cancer WP2828,0.19091722553209955,1.6885674451028232,2.796124699589355,"['RPS6KA5', 'CDKN2A', 'DAPK2', 'HRAS', 'FGFR3', 'VEGFA']",0.9585248613520372,0,0,6
96,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.197385952930124,1.7821290678433535,2.891672493989439,"['TGFBR3', 'TGFB1', 'HGF', 'MFGE8', 'HRAS']",0.9585248613520372,0,0,5
97,Genes controlling nephrogenesis WP4823,0.197385952930124,1.7821290678433535,2.891672493989439,"['CD36', 'ETV4', 'GLI3', 'FGFR2', 'VEGFA']",0.9585248613520372,0,0,5
98,Glycosylation and related congenital defects WP4521,0.197385952930124,1.7821290678433535,2.891672493989439,"['DPM2', 'DPM3', 'MPI', 'MAGT1', 'MPDU1']",0.9585248613520372,0,0,5
99,NRF2-ARE regulation WP4357,0.197385952930124,1.7821290678433535,2.891672493989439,"['AIMP2', 'CEBPB', 'PGAM5', 'SLC7A11', 'EPHB2']",0.9585248613520372,0,0,5
100,Computational Model of Aerobic Glycolysis WP4629,0.20018919266324003,2.2906729634002363,3.684530043945887,"['LDHA', 'PKM', 'PFKM']",0.9585248613520372,0,0,3
101,Cysteine and methionine catabolism WP4504,0.20018919266324003,2.2906729634002363,3.684530043945887,"['AHCY', 'GOT1', 'GSS']",0.9585248613520372,0,0,3
102,Glycolysis in senescence WP5049,0.20018919266324003,2.2906729634002363,3.684530043945887,"['LDHA', 'PKM', 'ALDOC']",0.9585248613520372,0,0,3
103,Kynurenine Pathway and links to Cellular Senescence WP5044,0.20018919266324003,2.2906729634002363,3.684530043945887,"['KMO', 'FOXO1', 'ACMSD']",0.9585248613520372,0,0,3
104,Mammalian disorder of sexual development WP4842,0.20018919266324003,2.2906729634002363,3.684530043945887,"['FGF9', 'PTGDS', 'FGFR2']",0.9585248613520372,0,0,3
105,Canonical and non-canonical Notch signaling WP3845,0.2016973163848881,1.9438709030770773,3.1121123158848283,"['MAML2', 'MAML1', 'CNTN6', 'PSEN2']",0.9585248613520372,0,0,4
106,Constitutive Androstane Receptor Pathway WP2875,0.2016973163848881,1.9438709030770773,3.1121123158848283,"['HSP90AA1', 'ABCB1', 'CYP3A5', 'FOXO1']",0.9585248613520372,0,0,4
107,Gastric Cancer Network 1 WP2361,0.2016973163848881,1.9438709030770773,3.1121123158848283,"['SMOC2', 'ACTL6A', 'GATD3B', 'KIF15']",0.9585248613520372,0,0,4
108,One-carbon metabolism WP241,0.2016973163848881,1.9438709030770773,3.1121123158848283,"['ALDH1L1', 'AHCY', 'CHDH', 'GLRX']",0.9585248613520372,0,0,4
109,Striated Muscle Contraction Pathway WP383,0.2016973163848881,1.9438709030770773,3.1121123158848283,"['MYOM1', 'TNNT2', 'VIM', 'ACTG1']",0.9585248613520372,0,0,4
110,Base Excision Repair WP4752,0.21734228667635,1.6039735099337749,2.448115592268311,"['POLE4', 'PCNA', 'NEIL2', 'APEX1', 'POLE2', 'POLE3']",0.9999803516166453,0,0,6
111,Complement system WP2806,0.21734228667635,1.6039735099337749,2.448115592268311,"['PRNP', 'RPS19', 'ITGA2B', 'CD59', 'CALR', 'DCN']",0.9999803516166453,0,0,6
112,Methionine De Novo and Salvage Pathway WP3580,0.23760778996967064,1.7816979051819184,2.5605384697210067,"['AHCY', 'CHDH', 'ODC1', 'SRM']",0.9999803516166453,0,0,4
113,Nucleotide metabolism WP404,0.23760778996967064,1.7816979051819184,2.5605384697210067,"['PRPS1', 'NME2', 'OAZ1', 'SRM']",0.9999803516166453,0,0,4
114,Ovarian infertility WP34,0.23760778996967064,1.7816979051819184,2.5605384697210067,"['CEBPB', 'CDKN1B', 'SMPD1', 'INHA']",0.9999803516166453,0,0,4
115,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.24178148759483348,2.671806167400881,3.79321906875873,"['TCF7', 'VEGFA']",0.9999803516166453,0,0,2
116,Aspirin and miRNAs WP4707,0.24178148759483348,2.671806167400881,3.79321906875873,"['MVD', 'VEGFA']",0.9999803516166453,0,0,2
117,Eicosanoid Synthesis WP167,0.24178148759483348,2.671806167400881,3.79321906875873,"['PTGES2', 'PTGDS']",0.9999803516166453,0,0,2
118,IL1 and megakaryocytes in obesity WP2865,0.24178148759483348,2.671806167400881,3.79321906875873,"['F2R', 'TIMP2']",0.9999803516166453,0,0,2
119,Sulfation Biotransformation Reaction WP692,0.24178148759483348,2.671806167400881,3.79321906875873,"['SULT4A1', 'PAPSS2']",0.9999803516166453,0,0,2
120,Transcriptional cascade regulating adipogenesis WP4211,0.24178148759483348,2.671806167400881,3.79321906875873,"['CEBPB', 'DDIT3']",0.9999803516166453,0,0,2
121,TYROBP causal network in microglia WP3945,0.24492651263749635,2.0041322314049586,2.8194073346980106,"['DPYD', 'LOXL3', 'LHFPL2']",0.9999803516166453,0,0,3
122,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.2502392195126982,1.3749822316986495,1.9048150532024641,"['SFRP4', 'SFRP1', 'PORCN', 'JUN', 'WNT5B', 'TCF7', 'ROR2', 'CXXC4', 'DKK2']",0.9999803516166453,0,0,9
123,Head and Neck Squamous Cell Carcinoma WP4674,0.2615764403894784,1.3071757978232799,1.7529602910587214,"['CDK6', 'MAML1', 'CDKN2A', 'RPS6', 'DDIT4', 'GAB1', 'FAT1', 'HRAS', 'FGFR3', 'FGFR2', 'VEGFA']",0.9999803516166453,0,0,11
124,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.26559486695393997,1.283455149501661,1.701583259497255,"['IDI1', 'SQLE', 'HMGCS1', 'SCD', 'INSIG1', 'FASN', 'CYP51A1', 'MVD', 'HMGCR', 'LSS', 'LDLR', 'FDFT1']",0.9999803516166453,0,0,12
125,G1 to S cell cycle control WP45,0.26579495009072523,1.3797184102655498,1.8281684669868359,"['CDKN1B', 'PCNA', 'CDK6', 'CDKN2A', 'GADD45A', 'RPA3', 'POLE2', 'MCM6']",0.9999803516166453,0,0,8
126,DNA Replication WP466,0.27339954141437883,1.4578567128236002,1.8905792468857643,"['PCNA', 'DBF4', 'RPA3', 'POLE2', 'GMNN', 'MCM6']",0.9999803516166453,0,0,6
127,GABA receptor Signaling WP4159,0.27339954141437883,1.4578567128236002,1.8905792468857643,"['GABBR1', 'SLC32A1', 'GAD1', 'GAD2', 'SLC6A1', 'GABRD']",0.9999803516166453,0,0,6
128,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.2748396806067717,1.6444745992706302,2.123949668955559,"['FBN2', 'TGFBR3', 'ANGPT2', 'RUNX2']",0.9999803516166453,0,0,4
129,Sleep regulation WP3591,0.2748396806067717,1.6444745992706302,2.123949668955559,"['AHCY', 'CRH', 'PTGDS', 'HCRTR2']",0.9999803516166453,0,0,4
130,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.288887013488481,1.1319974143503555,1.4056234038298583,"['CDKN1B', 'COL11A1', 'ITGA2B', 'HIF3A', 'FGF1', 'FOXO1', 'THBS4', 'GHR', 'LIPE', 'RELN', 'FGF9', 'GNG4', 'PDGFC', 'HRAS', 'HSP90AA1', 'ANGPT2', 'HGF', 'RPS6', 'F2R', 'FN1', 'VEGFB', 'PPP2R5B', 'IGF1', 'VEGFA', 'EFNA3', 'COL5A1', 'PIK3IP1', 'COL5A3', 'DDIT4', 'KIT', 'COL5A2', 'FGFR3', 'FGFR2']",0.9999803516166453,0,0,33
131,Drug Induction of Bile Acid Pathway WP2289,0.29059297749322544,5.34232250963126,6.602211475267051,['ABCB1'],0.9999803516166453,0,0,1
132,EV release from cardiac cells and their functional effects WP3297,0.29059297749322544,5.34232250963126,6.602211475267051,['RGS16'],0.9999803516166453,0,0,1
133,Airway smooth muscle cell contraction WP4962,0.2909869412047264,1.781267217630854,2.1989332122347007,"['RYR1', 'PPP1R14A', 'MYLK']",0.9999803516166453,0,0,3
134,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.2909869412047264,1.781267217630854,2.1989332122347007,"['CD81', 'IGF1', 'PDLIM5']",0.9999803516166453,0,0,3
135,Cancer immunotherapy by PD-1 blockade WP4585,0.3050725066338999,2.1372246696035244,2.5373255321170367,"['JUN', 'HLA-A']",0.9999803516166453,0,0,2
136,Dual hijack model of Vif in HIV infection WP3300,0.3050725066338999,2.1372246696035244,2.5373255321170367,"['ELOB', 'RUNX1']",0.9999803516166453,0,0,2
137,Osteoclast Signaling WP12,0.3050725066338999,2.1372246696035244,2.5373255321170367,"['AIMP2', 'ATP6V1G1']",0.9999803516166453,0,0,2
138,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.3050725066338999,2.1372246696035244,2.5373255321170367,"['BUB3', 'ANAPC11']",0.9999803516166453,0,0,2
139,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.31486808192307664,1.2958312405826218,1.4974645453436366,"['PPP1R15A', 'PPP1R14A', 'PPP1R14B', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'DDIT3']",0.9999803516166453,0,0,8
140,Modulators of TCR signaling and T cell activation WP5072,0.31486808192307664,1.2958312405826218,1.4974645453436366,"['FIBP', 'CDKN1B', 'NDUFB10', 'ELOB', 'LCP2', 'RNF7', 'CD247', 'ZFP36L1']",0.9999803516166453,0,0,8
141,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.3209176321016083,1.2431827536530151,1.4129652001986042,"['SFRP4', 'SFRP1', 'PORCN', 'JUN', 'CDK6', 'WNT5B', 'TCF7', 'ROR2', 'CXXC4', 'DKK2']",0.9999803516166453,0,0,10
142,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.32502195437478965,1.4063633988446018,1.5805591514492419,"['LDHA', 'ANGPT2', 'PKM', 'BAX', 'VEGFA']",0.9999803516166453,0,0,5
143,The influence of laminopathies on Wnt signaling WP4844,0.32502195437478965,1.4063633988446018,1.5805591514492419,"['CEBPB', 'ICMT', 'CDK6', 'TCF7', 'RUNX2']",0.9999803516166453,0,0,5
144,Copper homeostasis WP3286,0.33236899835667233,1.336092715231788,1.4717188005716688,"['PRNP', 'JUN', 'CCS', 'COX17', 'FOXO1', 'ATOX1']",0.9999803516166453,0,0,6
145,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.3375466204539104,1.6029752066115703,1.7409138576799654,"['FGF9', 'FGFR2', 'GADD45G']",0.9999803516166453,0,0,3
146,Omega-9 FA synthesis WP4724,0.3375466204539104,1.6029752066115703,1.7409138576799654,"['SCD', 'FASN', 'ACOT2']",0.9999803516166453,0,0,3
147,Angiogenesis WP1539,0.35142133691604344,1.424917309812569,1.4901348992347452,"['TIMP2', 'TIMP3', 'FGFR2', 'VEGFA']",0.9999803516166453,0,0,4
148,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.35142133691604344,1.424917309812569,1.4901348992347452,"['NDUFA13', 'HSP90AA1', 'RIPK2', 'AAMP']",0.9999803516166453,0,0,4
149,Signaling of Hepatocyte Growth Factor Receptor WP313,0.3624380882212523,1.2825165562913907,1.3016281183289653,"['JUN', 'HGF', 'ITGA1', 'GAB1', 'PTK2B', 'HRAS']",0.9999803516166453,0,0,6
150,miRNA regulation of DNA damage response WP1530,0.36551289796130787,1.2215311760063141,1.2294145862627106,"['CDKN1B', 'CDK6', 'GADD45A', 'CCNG1', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.9999803516166453,0,0,8
151,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.36556554539834807,1.1876843657817109,1.1951782801219428,"['PSMD8', 'TUBB2B', 'PSMC5', 'TUBA1A', 'TUBB2A', 'HSPA5', 'TUBB', 'UBE2L6', 'STUB1', 'TUBA8']",0.9999803516166453,0,0,10
152,Glutathione metabolism WP100,0.3672710406195706,1.7808370044052864,1.7837845981033504,"['GPX4', 'GSS']",0.9999803516166453,0,0,2
153,Leptin and adiponectin WP3934,0.3672710406195706,1.7808370044052864,1.7837845981033504,"['LEPR', 'ADIPOR1']",0.9999803516166453,0,0,2
154,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.3672710406195706,1.7808370044052864,1.7837845981033504,"['SFRP1', 'TGFB1']",0.9999803516166453,0,0,2
155,Serotonin and anxiety-related events WP3944,0.3672710406195706,1.7808370044052864,1.7837845981033504,"['CRH', 'HTR2C']",0.9999803516166453,0,0,2
156,Trans-sulfuration pathway WP2333,0.3672710406195706,1.7808370044052864,1.7837845981033504,"['AHCY', 'GOT1']",0.9999803516166453,0,0,2
157,Vitamin B12 metabolism WP1533,0.38389711083177025,1.45709992486852,1.3949993501775044,"['PLAT', 'APOE', 'LDLR']",0.9999803516166453,0,0,3
158,Glucocorticoid Receptor Pathway WP2880,0.3921601004572139,1.2065869863379706,1.129468103431118,"['TGFBR3', 'RGS2', 'HSP90AA1', 'JUN', 'B3GNT5', 'PLK2', 'MFGE8']",0.9999803516166453,0,0,7
159,Aryl Hydrocarbon Receptor Netpath WP2586,0.3926382725393502,1.2330616403464085,1.1527480410477233,"['HSP90AA1', 'CDKN1B', 'AIP', 'CD36', 'HRAS', 'VEGFA']",0.9999803516166453,0,0,6
160,Nephrotic syndrome WP4758,0.3926382725393502,1.2330616403464085,1.1527480410477233,"['MYO1E', 'ANLN', 'TRPC6', 'INF2', 'GPC5', 'WDR73']",0.9999803516166453,0,0,6
161,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.40250726025031697,2.670886075949367,2.430618891997621,['EPHX2'],0.9999803516166453,0,0,1
162,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.40250726025031697,2.670886075949367,2.430618891997621,['GSS'],0.9999803516166453,0,0,1
163,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.40250726025031697,2.670886075949367,2.430618891997621,['ABCB1'],0.9999803516166453,0,0,1
164,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.40250726025031697,2.670886075949367,2.430618891997621,['CD247'],0.9999803516166453,0,0,1
165,Platelet-mediated interactions with vascular and circulating cells WP4462,0.40250726025031697,2.670886075949367,2.430618891997621,['TGFB1'],0.9999803516166453,0,0,1
166,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.40250726025031697,2.670886075949367,2.430618891997621,['VEGFA'],0.9999803516166453,0,0,1
167,Small Ligand GPCRs WP247,0.40250726025031697,2.670886075949367,2.430618891997621,['PTGFR'],0.9999803516166453,0,0,1
168,Tamoxifen metabolism WP691,0.40250726025031697,2.670886075949367,2.430618891997621,['CYP3A5'],0.9999803516166453,0,0,1
169,Tgif disruption of Shh signaling WP3674,0.40250726025031697,2.670886075949367,2.430618891997621,['GLI3'],0.9999803516166453,0,0,1
170,Vitamin B6-dependent and responsive disorders WP4228,0.40250726025031697,2.670886075949367,2.430618891997621,['PNPO'],0.9999803516166453,0,0,1
171,Eukaryotic Transcription Initiation WP405,0.41980246860563286,1.1687603533959139,1.014450082389206,"['GTF2A2', 'TAF13', 'POLR2E', 'TAF7', 'POLR2I', 'GTF2H4', 'POLR2K']",0.9999803516166453,0,0,7
172,One-carbon metabolism and related pathways WP3940,0.422788437802346,1.1872700515084622,1.0221010455246426,"['GPX4', 'CHDH', 'GAD1', 'GSS', 'GAD2', 'PLD1']",0.9999803516166453,0,0,6
173,Prader-Willi and Angelman Syndrome WP3998,0.422788437802346,1.1872700515084622,1.0221010455246426,"['CDK6', 'DLX5', 'CDKN2A', 'HTR2C', 'NDN', 'GABRD']",0.9999803516166453,0,0,6
174,TGF-beta Receptor Signaling WP560,0.422788437802346,1.1872700515084622,1.0221010455246426,"['TGFBR3', 'JUN', 'TGFB1', 'SMAD9', 'HRAS', 'RUNX2']",0.9999803516166453,0,0,6
175,Biomarkers for pyrimidine metabolism disorders WP4584,0.42714752456804345,1.526274386406545,1.298288423811523,"['NT5C', 'DPYD']",0.9999803516166453,0,0,2
176,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.42714752456804345,1.526274386406545,1.298288423811523,"['TULP3', 'SOX4']",0.9999803516166453,0,0,2
177,Hypertrophy Model WP516,0.42714752456804345,1.526274386406545,1.298288423811523,"['WDR1', 'VEGFA']",0.9999803516166453,0,0,2
178,Major receptors targeted by epinephrine and norepinephrine WP4589,0.42714752456804345,1.526274386406545,1.298288423811523,"['ADCY10', 'ADRA1D']",0.9999803516166453,0,0,2
179,miRNAs involved in DNA damage response WP1545,0.42714752456804345,1.526274386406545,1.298288423811523,"['CDKN1B', 'CDK6']",0.9999803516166453,0,0,2
180,Purine metabolism WP4792,0.42714752456804345,1.526274386406545,1.298288423811523,"['PRPS1', 'APRT']",0.9999803516166453,0,0,2
181,Pyrimidine metabolism and related diseases WP4225,0.42714752456804345,1.526274386406545,1.298288423811523,"['NT5C', 'DPYD']",0.9999803516166453,0,0,2
182,Hematopoietic Stem Cell Differentiation WP2849,0.4294470433121501,1.3355371900826447,1.1288719498237494,"['ITGA2B', 'PIM1', 'RUNX1']",0.9999803516166453,0,0,3
183,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.4294470433121501,1.3355371900826447,1.1288719498237494,"['EIF1AX', 'EIF3I', 'EIF3D']",0.9999803516166453,0,0,3
184,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.4294470433121501,1.3355371900826447,1.1288719498237494,"['JUN', 'SRXN1', 'GSTP1']",0.9999803516166453,0,0,3
185,Type II interferon signaling (IFNG) WP619,0.4294470433121501,1.3355371900826447,1.1288719498237494,"['PRKCD', 'HLA-B', 'IFIT2']",0.9999803516166453,0,0,3
186,Androgen receptor signaling pathway WP138,0.4418429985456773,1.0852839335180056,0.8864606406902805,"['JUN', 'RNF6', 'PARK7', 'ETV5', 'RUNX2', 'FOXO1', 'SUMO1', 'KAT5', 'BAG1', 'STUB1', 'CALR', 'FKBP4', 'RAN']",0.9999803516166453,0,0,13
187,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.44238681542349667,1.124745565571387,0.9173094513093621,"['MYO1E', 'CDKN1B', 'TRPC6', 'INF2', 'PCNA', 'TGFB1', 'FAT1', 'VIM']",0.9999803516166453,0,0,8
188,Genotoxicity pathway WP4286,0.4527202090379824,1.1447492904446548,0.9071920445943145,"['RPS27', 'GADD45A', 'BLOC1S2', 'ID2', 'PCDH8', 'PHLDA3']",0.9999803516166453,0,0,6
189,Tumor suppressor activity of SMARCB1 WP4204,0.4587330158311264,1.1612988321062856,0.9049849703414179,"['CDK6', 'H3F3B', 'CDKN2A', 'ACTL6A', 'GLI3']",0.9999803516166453,0,0,5
190,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.4737176207515319,1.2326764144945963,0.9209866287799756,"['FGF1', 'RUNX2', 'FGFR2']",0.9999803516166453,0,0,3
191,Pre-implantation embryo WP3527,0.4737176207515319,1.2326764144945963,0.9209866287799756,"['DLX2', 'DDIT3', 'ATP1A1']",0.9999803516166453,0,0,3
192,Proteoglycan biosynthesis WP4784,0.4737176207515319,1.2326764144945963,0.9209866287799756,"['XYLT1', 'B4GALT7', 'PAPSS2']",0.9999803516166453,0,0,3
193,DNA damage response WP707,0.47458993591464305,1.0997823756780458,0.8196723583634264,"['CDKN1B', 'CDK6', 'GADD45A', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.9999803516166453,0,0,7
194,Differentiation of white and brown adipocyte WP2895,0.48388708064106234,1.335352422907489,0.9693372698615977,"['CEBPB', 'SMAD9']",0.9999803516166453,0,0,2
195,Fatty acid transporters WP5061,0.48388708064106234,1.335352422907489,0.9693372698615977,"['FABP3', 'CD36']",0.9999803516166453,0,0,2
196,"GPCRs, Class B Secretin-like WP334",0.48388708064106234,1.335352422907489,0.9693372698615977,"['VIPR2', 'ADGRG2']",0.9999803516166453,0,0,2
197,RalA downstream regulated genes WP2290,0.48388708064106234,1.335352422907489,0.9693372698615977,"['EXOC8', 'HRAS']",0.9999803516166453,0,0,2
198,Melanoma WP4685,0.48545693080373237,1.06832504145937,0.7720408022098724,"['CDK6', 'CDKN2A', 'GADD45A', 'KIT', 'BAX', 'CALM3', 'ETS1', 'HRAS', 'GADD45G']",0.9999803516166453,0,0,9
199,Proteasome Degradation WP183,0.48545693080373237,1.06832504145937,0.7720408022098724,"['PSMD8', 'PSMB6', 'PSMC5', 'H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMB10']",0.9999803516166453,0,0,9
200,Neural Crest Differentiation WP2064,0.492987814124875,1.0682872928176796,0.7555684328390118,"['HDAC10', 'DLX5', 'LHX2', 'ASCL1', 'ETS1', 'FGFR3', 'FGFR2', 'GFAP']",0.9999803516166453,0,0,8
201,Osteoblast differentiation WP4787,0.4937748903125949,1.0492133765515061,0.740404230004347,"['PRKCH', 'FGF9', 'WNT5B', 'PRKCD', 'SMAD9', 'PRKD1', 'FGF1', 'FGFR3', 'RUNX2', 'FGFR2', 'GLI3']",0.9999803516166453,0,0,11
202,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.49677437710677463,1.7804072647220694,1.2456073297758465,['APOE'],0.9999803516166453,0,0,1
203,Bile acids synthesis and enterohepatic circulation  WP4389,0.49677437710677463,1.7804072647220694,1.2456073297758465,['LDLR'],0.9999803516166453,0,0,1
204,Blood Clotting Cascade WP272,0.49677437710677463,1.7804072647220694,1.2456073297758465,['PLAT'],0.9999803516166453,0,0,1
205,FOXP3 in COVID-19 WP5063,0.49677437710677463,1.7804072647220694,1.2456073297758465,['IL6ST'],0.9999803516166453,0,0,1
206,Metastatic brain tumor WP2249,0.49677437710677463,1.7804072647220694,1.2456073297758465,['CDK6'],0.9999803516166453,0,0,1
207,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.49677437710677463,1.7804072647220694,1.2456073297758465,['STRADB'],0.9999803516166453,0,0,1
208,Nanoparticle triggered regulated necrosis WP2513,0.49677437710677463,1.7804072647220694,1.2456073297758465,['FTL'],0.9999803516166453,0,0,1
209,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.49677437710677463,1.7804072647220694,1.2456073297758465,['VEGFA'],0.9999803516166453,0,0,1
210,Role of Osx and miRNAs in tooth development WP3971,0.49677437710677463,1.7804072647220694,1.2456073297758465,['RUNX2'],0.9999803516166453,0,0,1
211,Neovascularisation processes WP4331,0.5021711237552712,1.1244704926594324,0.7745513928331187,"['TGFB1', 'KIT', 'SMAD9', 'EPHB2']",0.9999803516166453,0,0,4
212,PI3K-Akt signaling pathway WP4172,0.5034086726119837,1.0141449324611334,0.69606138473815,"['CDKN1B', 'ITGA2B', 'FGF1', 'THBS4', 'GHR', 'RELN', 'FGF9', 'GNG4', 'PDGFC', 'HRAS', 'HSP90AA1', 'ANGPT2', 'HGF', 'RPS6', 'F2R', 'ITGA1', 'FN1', 'VEGFB', 'PPP2R5B', 'IGF1', 'VEGFA', 'EFNA3', 'CDK6', 'IL7', 'DDIT4', 'KIT', 'COL6A6', 'SGK1', 'FGFR3', 'FGFR2']",0.9999803516166453,0,0,30
213,IL-6 signaling pathway WP364,0.5113271869087823,1.0682119205298013,0.716498452166907,"['PRKCD', 'GAB1', 'VIP', 'IL6ST', 'JUNB', 'AGT']",0.9999803516166453,0,0,6
214,Metabolic reprogramming in colon cancer WP4290,0.5113271869087823,1.0682119205298013,0.716498452166907,"['LDHA', 'PKM', 'MDH2', 'PGAM1', 'FASN', 'PDHB']",0.9999803516166453,0,0,6
215,Pathogenic Escherichia coli infection WP2272,0.5113271869087823,1.0682119205298013,0.716498452166907,"['TUBB2B', 'TUBA1A', 'TUBB2A', 'TUBB', 'ACTG1', 'TUBA8']",0.9999803516166453,0,0,6
216,Breast cancer pathway WP4262,0.5128422580071967,1.0242839352428394,0.6840034659048574,"['JUN', 'SHC3', 'WNT5B', 'GADD45A', 'TCF7', 'IGF1', 'FGF1', 'GADD45G', 'SFRP4', 'CDK6', 'FGF9', 'KIT', 'BAX', 'HRAS']",0.9999803516166453,0,0,14
217,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.5163342999366444,1.1445100354191264,0.756522112176694,"['TICAM2', 'PLAT', 'TIRAP']",0.9999803516166453,0,0,3
218,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5163342999366444,1.1445100354191264,0.756522112176694,"['HTR7', 'RPS6KA5', 'HTR4']",0.9999803516166453,0,0,3
219,Parkinson's disease pathway WP2371,0.523033331798934,1.0681742967457253,0.6922945342788536,"['PINK1', 'HTRA2', 'CYCS', 'UBE2L6', 'PARK7']",0.9999803516166453,0,0,5
220,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5356384866472484,1.0128236933000019,0.6323015886802572,"['SHC3', 'HGF', 'RPS6', 'PDGFC', 'GAB1', 'BAX', 'IGF1', 'HRAS', 'FGFR3', 'FGFR2', 'VEGFA']",0.9999803516166453,0,0,11
221,Cell Differentiation - Index expanded WP2023,0.5369893980271938,1.1868575624082232,0.7379606486937038,"['ID2', 'RUNX2']",0.9999803516166453,0,0,2
222,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5369893980271938,1.1868575624082232,0.7379606486937038,"['RYR1', 'CCK']",0.9999803516166453,0,0,2
223,Cori Cycle WP1946,0.5369893980271938,1.1868575624082232,0.7379606486937038,"['LDHA', 'PGAM1']",0.9999803516166453,0,0,2
224,FOXA2 pathway WP5066,0.5369893980271938,1.1868575624082232,0.7379606486937038,"['FASN', 'FOXO1']",0.9999803516166453,0,0,2
225,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.5369893980271938,1.1868575624082232,0.7379606486937038,"['IL6ST', 'SOX4']",0.9999803516166453,0,0,2
226,Overview of nanoparticle effects WP3287,0.5369893980271938,1.1868575624082232,0.7379606486937038,"['FN1', 'BAX']",0.9999803516166453,0,0,2
227,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.5369893980271938,1.1868575624082232,0.7379606486937038,"['BCL2L2', 'VEGFA']",0.9999803516166453,0,0,2
228,Riboflavin and CoQ disorders WP5037,0.5369893980271938,1.1868575624082232,0.7379606486937038,"['FLAD1', 'RFK']",0.9999803516166453,0,0,2
229,Serotonin and anxiety WP3947,0.5369893980271938,1.1868575624082232,0.7379606486937038,"['CRH', 'HTR2C']",0.9999803516166453,0,0,2
230,Tryptophan catabolism leading to NAD+ production WP4210,0.5369893980271938,1.1868575624082232,0.7379606486937038,"['NMNAT1', 'KMO']",0.9999803516166453,0,0,2
231,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.5397403048096197,1.0336466566972868,0.6374159607575511,"['TGFBR3', 'JUN', 'TGFB1', 'SMAD9', 'HRAS', 'RUNX2']",0.9999803516166453,0,0,6
232,Apoptosis WP254,0.5421986124345733,1.017205998421468,0.622655086729716,"['HRK', 'JUN', 'CDKN2A', 'CYCS', 'BAX', 'IGF1', 'BCL2L2', 'BBC3']",0.9999803516166453,0,0,8
233,Endometrial cancer WP4155,0.5421986124345733,1.017205998421468,0.622655086729716,"['GADD45A', 'TCF7', 'BAX', 'FGF1', 'HRAS', 'FGFR3', 'FGFR2', 'GADD45G']",0.9999803516166453,0,0,8
234,Cell cycle WP179,0.5471402054034528,1.0012458471760797,0.6038015007748381,"['TGFB1', 'CDK6', 'CDKN1B', 'DBF4', 'PCNA', 'GADD45A', 'CDKN2A', 'MCM6', 'BUB3', 'CDC14B', 'ANAPC11', 'GADD45G']",0.9999803516166453,0,0,12
235,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5538213851440982,1.0102974316116227,0.5969979404661179,"['IFI27L2', 'JUN', 'PRKCH', 'PRKCD', 'ETS1', 'HRAS', 'RXRG']",0.9999803516166453,0,0,7
236,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5570163346527867,1.068099173553719,0.6250096743335387,"['RPS6', 'SGK1', 'FOXO1']",0.9999803516166453,0,0,3
237,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5570163346527867,1.068099173553719,0.6250096743335387,"['B3GALNT1', 'B3GALT2', 'B3GALT1']",0.9999803516166453,0,0,3
238,Oxidation by Cytochrome P450 WP43,0.5570163346527867,1.068099173553719,0.6250096743335387,"['CYB5R1', 'CYP51A1', 'CYP3A5']",0.9999803516166453,0,0,3
239,Oxidative Damage WP3941,0.5717062140987373,1.0171680579618838,0.5687292080464385,"['PCNA', 'CDKN1B', 'GADD45A', 'CYCS']",0.9999803516166453,0,0,4
240,Farnesoid X receptor pathway WP2879,0.5761757198043863,1.3351678591084204,0.7361349131434265,['FKBP5'],0.9999803516166453,0,0,1
241,Inflammatory Response Pathway WP453,0.5761757198043863,1.3351678591084204,0.7361349131434265,['FN1'],0.9999803516166453,0,0,1
242,Irinotecan pathway WP229,0.5761757198043863,1.3351678591084204,0.7361349131434265,['CYP3A5'],0.9999803516166453,0,0,1
243,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.5761757198043863,1.3351678591084204,0.7361349131434265,['ACOT2'],0.9999803516166453,0,0,1
244,miRNA Biogenesis WP2338,0.5761757198043863,1.3351678591084204,0.7361349131434265,['RAN'],0.9999803516166453,0,0,1
245,Mitochondrial fatty acid synthesis pathway WP4317,0.5761757198043863,1.3351678591084204,0.7361349131434265,['HSD17B12'],0.9999803516166453,0,0,1
246,Peroxiredoxin 2 induced ovarian failure WP4873,0.5761757198043863,1.3351678591084204,0.7361349131434265,['BAX'],0.9999803516166453,0,0,1
247,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.5761757198043863,1.3351678591084204,0.7361349131434265,['FOXO1'],0.9999803516166453,0,0,1
248,Vitamin D Metabolism WP1531,0.5761757198043863,1.3351678591084204,0.7361349131434265,['DHCR7'],0.9999803516166453,0,0,1
249,T-cell receptor (TCR) signaling pathway WP69,0.5770154488345425,0.9807087013910042,0.5392782187961271,"['JUN', 'TGFB1', 'RIPK2', 'PRKCD', 'PTK2B', 'LCP2', 'CD247', 'VIM', 'HRAS']",0.9999803516166453,0,0,9
250,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.5837834303372085,0.9888459888459888,0.5322218334731416,"['HSP90AA1', 'JUN', 'CDKN2A', 'BAX', 'JUNB']",0.9999803516166453,0,0,5
251,VEGFA-VEGFR2 Signaling Pathway WP3888,0.5838775636901896,0.9770787807251208,0.5257308871238614,"['NRP2', 'TRAF3IP2', 'RPL10A', 'ETS1', 'RPL7', 'HERPUD1', 'ACTG1', 'RPS6KA5', 'RPL18A', 'TMSB4X', 'RPLP2', 'ATP6V1E1', 'EPHB2', 'IER5', 'HRAS', 'HSP90AA1', 'SSR4', 'TRPC3', 'PRKCD', 'RPS6', 'GAB1', 'RPL13A', 'RCN1', 'KATNAL2', 'RPL27', 'PRKD1', 'RPL26', 'ARF6', 'SET', 'EPB41', 'ACACB', 'APOLD1', 'FOXO1', 'SCUBE2', 'LDHA', 'DNAJB4', 'DNAJB9', 'PTK2B', 'IGFBP7', 'MYH11', 'CCT7', 'TXNDC5', 'JUN', 'FN1', 'RAB11A', 'VEGFA', 'DNAJA1', 'PTPN9', 'CYCS', 'CALR', 'EIF3D', 'EIF4G2']",0.9999803516166453,0,0,52
252,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.5861898550304857,1.0680616740088105,0.5704640838725097,"['PTGFR', 'PTGDS']",0.9999803516166453,0,0,2
253,ERK Pathway in Huntington's Disease WP3853,0.5861898550304857,1.0680616740088105,0.5704640838725097,"['RPS6KA5', 'HRAS']",0.9999803516166453,0,0,2
254,GDNF/RET signaling axis WP4830,0.5861898550304857,1.0680616740088105,0.5704640838725097,"['SALL1', 'GLI3']",0.9999803516166453,0,0,2
255,Type II diabetes mellitus WP1584,0.5861898550304857,1.0680616740088105,0.5704640838725097,"['SURF1', 'PRKCD']",0.9999803516166453,0,0,2
256,Urea cycle and metabolism of amino groups WP497,0.5861898550304857,1.0680616740088105,0.5704640838725097,"['ODC1', 'SRM']",0.9999803516166453,0,0,2
257,Pathways in clear cell renal cell carcinoma WP4018,0.5869163215574089,0.9707361222847949,0.5172790910743656,"['LDHA', 'PKM', 'TGFB1', 'FASN', 'BHLHE41', 'ALDOC', 'ACACB', 'PFKM', 'KCNJ2', 'VEGFA']",0.9999803516166453,0,0,10
258,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.5942495802285139,0.9708007224563516,0.5052589434668218,"['CEBPB', 'TGFB1', 'ICMT', 'TCF7', 'JUNB', 'RUNX2']",0.9999803516166453,0,0,6
259,Fatty Acid Biosynthesis WP357,0.5955653699402552,1.0012396694214876,0.5188865744041615,"['SCD', 'FASN', 'ACACB']",0.9999803516166453,0,0,3
260,Gastric Cancer Network 2 WP2363,0.5955653699402552,1.0012396694214876,0.5188865744041615,"['FANCI', 'DSCC1', 'UBE2T']",0.9999803516166453,0,0,3
261,IL-7 signaling pathway WP205,0.5955653699402552,1.0012396694214876,0.5188865744041615,"['CDKN1B', 'IL7', 'PTK2B']",0.9999803516166453,0,0,3
262,Metapathway biotransformation Phase I and II WP702,0.5959985640317615,0.9627133098061273,0.4982205244205059,"['NNMT', 'GPX4', 'EPHX2', 'GSTP1', 'GSS', 'CYP51A1', 'KCNAB1', 'SULT4A1', 'GAL3ST3', 'CYP3A5', 'FMO5']",0.9999803516166453,0,0,11
263,Acute viral myocarditis WP4298,0.6035958039892905,0.9582890880516501,0.4837927288447799,"['SGCD', 'ENDOG', 'CXADR', 'TGFB1', 'CYCS', 'BAX', 'EIF4G2']",0.9999803516166453,0,0,7
264,Synaptic Vesicle Pathway WP2267,0.6035958039892905,0.9582890880516501,0.4837927288447799,"['RAB3A', 'SLC32A1', 'SLC1A3', 'SLC17A7', 'PARK7', 'SYN3', 'CPLX3']",0.9999803516166453,0,0,7
265,Translation Factors WP107,0.6035958039892905,0.9582890880516501,0.4837927288447799,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF1AX', 'EIF3I', 'EIF4H', 'EIF3D']",0.9999803516166453,0,0,7
266,Nucleotide Excision Repair WP4753,0.6201782484027192,0.9421503700818076,0.4501107798957751,"['POLE4', 'PCNA', 'RPA3', 'POLE2', 'POLE3', 'GTF2H4']",0.9999803516166453,0,0,6
267,Globo Sphingolipid Metabolism WP1424,0.6313976789409168,0.9708650380456548,0.4464225588061549,"['B3GALNT1', 'ST6GAL1']",0.9999803516166453,0,0,2
268,Heart Development WP1591,0.6313976789409168,0.9708650380456548,0.4464225588061549,"['VEGFB', 'VEGFA']",0.9999803516166453,0,0,2
269,Kallmann's Syndrome WP5074,0.6313976789409168,0.9708650380456548,0.4464225588061549,"['ANOS1', 'ASCL1']",0.9999803516166453,0,0,2
270,Cell migration and invasion through p75NTR WP4561,0.6318539055795296,0.9422459893048128,0.43258237631535973,"['JUN', 'EFNA3', 'EFNB3']",0.9999803516166453,0,0,3
271,Endothelin Pathways WP2197,0.6318539055795296,0.9422459893048128,0.43258237631535973,"['ADCY10', 'NPY', 'MYLK']",0.9999803516166453,0,0,3
272,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.6318539055795296,0.9422459893048128,0.43258237631535973,"['FGF9', 'FGFR3', 'PTHLH']",0.9999803516166453,0,0,3
273,Physiological and pathological hypertrophy of the heart WP1528,0.6318539055795296,0.9422459893048128,0.43258237631535973,"['JUN', 'IL6ST', 'AGT']",0.9999803516166453,0,0,3
274,BDNF-TrkB Signaling WP3676,0.6354296625904535,0.9285269162552131,0.42104412812701636,"['TRPC6', 'TRPC3', 'GAB1', 'HRAS']",0.9999803516166453,0,0,4
275,Biomarkers for urea cycle disorders WP4583,0.6430545072405321,1.068024215740231,0.4715602336012268,['GOT1'],0.9999803516166453,0,0,1
276,Caloric restriction and aging WP4191,0.6430545072405321,1.068024215740231,0.4715602336012268,['IGF1'],0.9999803516166453,0,0,1
277,"Degradation pathway of sphingolipids, including diseases WP4153",0.6430545072405321,1.068024215740231,0.4715602336012268,['NEU1'],0.9999803516166453,0,0,1
278,Disorders of Folate Metabolism and Transport WP4259,0.6430545072405321,1.068024215740231,0.4715602336012268,['ALDH1L1'],0.9999803516166453,0,0,1
279,Insulin signaling in adipocytes (diabetic condition) WP3635,0.6430545072405321,1.068024215740231,0.4715602336012268,['RPS6'],0.9999803516166453,0,0,1
280,Insulin signaling in adipocytes (normal condition) WP3634,0.6430545072405321,1.068024215740231,0.4715602336012268,['RPS6'],0.9999803516166453,0,0,1
281,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.6430545072405321,1.068024215740231,0.4715602336012268,['AHCY'],0.9999803516166453,0,0,1
282,Methylation Pathways WP704,0.6430545072405321,1.068024215740231,0.4715602336012268,['NNMT'],0.9999803516166453,0,0,1
283,Selective expression of chemokine receptors during T-cell polarization WP4494,0.6430545072405321,1.068024215740231,0.4715602336012268,['TGFB1'],0.9999803516166453,0,0,1
284,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.6430545072405321,1.068024215740231,0.4715602336012268,['JUN'],0.9999803516166453,0,0,1
285,p53 transcriptional gene network WP4963,0.6451362261546525,0.9151371807000946,0.40109893519642964,"['GADD45A', 'CCNG1', 'BAX', 'SLC7A11', 'BBC3', 'RPRM']",0.9999803516166453,0,0,6
286,Glioblastoma signaling pathways WP2261,0.6466579871548992,0.9202395483674092,0.4011671467730286,"['CDKN1B', 'PRKCH', 'CDK6', 'CDKN2A', 'PRKCD', 'GAB1', 'SPRY2', 'HRAS', 'FOXO1', 'FGFR2']",0.9999803516166453,0,0,10
287,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6658141735130081,0.8898071625344353,0.3619243172397757,"['RAB3B', 'RAB3A', 'RAB11A']",0.9999803516166453,0,0,3
288,Interleukin-11 Signaling Pathway WP2332,0.6663874707415428,0.8896856039713182,0.36110914253143495,"['TGFB1', 'RPS6', 'IL6ST', 'HRAS', 'RUNX2']",0.9999803516166453,0,0,5
289,Phosphodiesterases in neuronal function WP4222,0.6690760472566107,0.8896247240618101,0.3575024140635946,"['ADCY10', 'PDE10A', 'PDE1A', 'PDE3A', 'PDE5A', 'PDE6B']",0.9999803516166453,0,0,6
290,Complement and Coagulation Cascades WP558,0.6726477345793254,0.8898678414096917,0.3528624203347425,"['F2R', 'PLAT']",0.9999803516166453,0,0,2
291,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6726477345793254,0.8898678414096917,0.3528624203347425,"['BAX', 'BBC3']",0.9999803516166453,0,0,2
292,Purinergic signaling WP4900,0.6726477345793254,0.8898678414096917,0.3528624203347425,"['P2RY12', 'P2RY14']",0.9999803516166453,0,0,2
293,Transcription co-factors SKI and SKIL protein partners WP4533,0.6726477345793254,0.8898678414096917,0.3528624203347425,"['SATB2', 'MERTK']",0.9999803516166453,0,0,2
294,Transcription factor regulation in adipogenesis WP3599,0.6726477345793254,0.8898678414096917,0.3528624203347425,"['CEBPB', 'FOXO1']",0.9999803516166453,0,0,2
295,Triacylglyceride synthesis WP325,0.6726477345793254,0.8898678414096917,0.3528624203347425,"['LIPE', 'AGPAT1']",0.9999803516166453,0,0,2
296,Urea cycle and associated pathways WP4595,0.6726477345793254,0.8898678414096917,0.3528624203347425,"['GOT1', 'MDH2']",0.9999803516166453,0,0,2
297,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6760118705505326,0.8895027624309392,0.3482800416590265,"['JUN', 'TGFB1', 'GADD45A', 'TCF7', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.9999803516166453,0,0,8
298,Hippo-Merlin Signaling Dysregulation WP4541,0.6876075764409866,0.8893193137797454,0.33308297613863785,"['PPP1R14A', 'LIN28B', 'PRKAR1A', 'ITGA2B', 'ITGA1', 'KIT', 'CDH24', 'FGFR3', 'HRAS', 'FGFR2', 'CDH18']",0.9999803516166453,0,0,11
299,DNA IR-double strand breaks and cellular response via ATM WP3959,0.691963187347132,0.8654913191337033,0.3186933965209996,"['DCLRE1C', 'PCNA', 'KAT5', 'CDKN2A', 'ACTL6A', 'BAX']",0.9999803516166453,0,0,6
300,Type 2 papillary renal cell carcinoma WP4241,0.6926587519417571,0.8540683572216097,0.31362912241528,"['TGFB1', 'COL21A1', 'ELOB', 'VEGFA']",0.9999803516166453,0,0,4
301,Non-small cell lung cancer WP4255,0.6958089349330512,0.8712594430037208,0.315988527354173,"['CDK6', 'CDKN2A', 'GADD45A', 'CYCS', 'BAX', 'HRAS', 'RXRG', 'GADD45G']",0.9999803516166453,0,0,8
302,Ethanol effects on histone modifications WP3996,0.6974277694289658,0.8428882122662027,0.30374010026339215,"['AHCY', 'HDAC10', 'HAT1']",0.9999803516166453,0,0,3
303,Small cell lung cancer WP4658,0.6984372307293631,0.8731795567616463,0.31339284614088503,"['CDKN1B', 'CDK6', 'GADD45A', 'ITGA2B', 'FN1', 'CYCS', 'BAX', 'RXRG', 'GADD45G']",0.9999803516166453,0,0,9
304,"Cerebral organic acidurias, including diseases WP4519",0.6993847802336612,0.8899284534947716,0.3181976702766533,['MDH2'],0.9999803516166453,0,0,1
305,HIF1A and PPARG regulation of glycolysis WP2456,0.6993847802336612,0.8899284534947716,0.3181976702766533,['LDHA'],0.9999803516166453,0,0,1
306,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.6993847802336612,0.8899284534947716,0.3181976702766533,['TGFB1'],0.9999803516166453,0,0,1
307,Neuroinflammation WP4919,0.6993847802336612,0.8899284534947716,0.3181976702766533,['JUN'],0.9999803516166453,0,0,1
308,Thiamine metabolic pathways WP4297,0.6993847802336612,0.8899284534947716,0.3181976702766533,['BCKDK'],0.9999803516166453,0,0,1
309,Pathways Regulating Hippo Signaling WP4540,0.7013121680595918,0.8747098505730451,0.3103489556143587,"['PRKCH', 'PRKD3', 'PRKAR1A', 'PRKCD', 'TCF7', 'KIT', 'CDH24', 'FGFR3', 'FGFR2', 'CDH18']",0.9999803516166453,0,0,10
310,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.7100631848894067,0.8213317519484921,0.2812250761108391,"['JUN', 'MYLK']",0.9999803516166453,0,0,2
311,Toll-like Receptor Signaling related to MyD88 WP3858,0.7100631848894067,0.8213317519484921,0.2812250761108391,"['TICAM2', 'TIRAP']",0.9999803516166453,0,0,2
312,Vitamin A and carotenoid metabolism WP716,0.7100631848894067,0.8213317519484921,0.2812250761108391,"['CD36', 'RXRG']",0.9999803516166453,0,0,2
313,AMP-activated protein kinase (AMPK) signaling WP1403,0.7138535427335202,0.8489533657948898,0.28616304411990223,"['LIPE', 'STRADB', 'FASN', 'LEPR', 'HMGCR', 'ADIPOR1', 'ACACB']",0.9999803516166453,0,0,7
314,Retinoblastoma gene in cancer WP2446,0.7148158755550039,0.8537458563535911,0.2866283406594036,"['ANLN', 'CDKN1B', 'PCNA', 'CDK6', 'H2AFZ', 'RPA3', 'POLE2', 'MCM6']",0.9999803516166453,0,0,8
315,PPAR signaling pathway WP3942,0.7150935331916619,0.8339078874793161,0.2796442797549692,"['FABP3', 'SCD', 'SLC27A6', 'CD36', 'RXRG']",0.9999803516166453,0,0,5
316,ESC Pluripotency Pathways WP3931,0.7182982184451391,0.8605124179274907,0.2847181310727297,"['JUN', 'FGF9', 'WNT5B', 'GAB1', 'SMAD9', 'FGF1', 'IL6ST', 'FGFR3', 'HRAS', 'FGFR2']",0.9999803516166453,0,0,10
317,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7187549432679262,0.8211347638029005,0.2711672821373927,"['IFITM3', 'JUN', 'DDIT3', 'JUNB']",0.9999803516166453,0,0,4
318,IL-2 signaling pathway WP49,0.7187549432679262,0.8211347638029005,0.2711672821373927,"['JUN', 'RPS6', 'PTK2B', 'HRAS']",0.9999803516166453,0,0,4
319,Gastrin signaling pathway WP4659,0.7229029442408162,0.8650444464397953,0.2806898868273195,"['JUN', 'PRKCH', 'CDKN1B', 'KAT5', 'CDKN2A', 'RPS6', 'PRKCD', 'KIT', 'PRKD1', 'HRAS', 'FOXO1', 'VEGFA']",0.9999803516166453,0,0,12
320,DNA Repair Pathways Full Network WP4946,0.741787473086834,0.8582078140530621,0.2563402385746683,"['FANCI', 'DCLRE1C', 'PCNA', 'CENPX', 'GTF2H4', 'POLE4', 'BRIP1', 'NEIL2', 'RPA3', 'POLE2', 'APEX1', 'POLE3', 'USP1', 'FAAP100']",0.9999803516166453,0,0,14
321,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7431753491644062,0.7906406958226142,0.23468054925063028,"['MAP1LC3A', 'IGFBP5', 'IGF1', 'PLD1']",0.9999803516166453,0,0,4
322,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7431753491644062,0.7906406958226142,0.23468054925063028,"['JUN', 'RIPK2', 'CYCS', 'ACTG1']",0.9999803516166453,0,0,4
323,Integrated Cancer Pathway WP1971,0.7431753491644062,0.7906406958226142,0.23468054925063028,"['CDKN1B', 'BAX', 'BACH1', 'BBC3']",0.9999803516166453,0,0,4
324,p38 MAPK Signaling Pathway WP400,0.7431753491644062,0.7906406958226142,0.23468054925063028,"['RPS6KA5', 'DDIT3', 'HRAS', 'HMGN1']",0.9999803516166453,0,0,4
325,Target Of Rapamycin (TOR) Signaling WP1471,0.7431753491644062,0.7906406958226142,0.23468054925063028,"['IDI1', 'RRAGA', 'DDIT4', 'HMGCR']",0.9999803516166453,0,0,4
326,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7438267948092205,0.7625865324103209,0.2256852528834091,"['H3F3B', 'H2AFZ']",0.9999803516166453,0,0,2
327,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7438267948092205,0.7625865324103209,0.2256852528834091,"['BAX', 'BBC3']",0.9999803516166453,0,0,2
328,Monoamine Transport WP727,0.7438267948092205,0.7625865324103209,0.2256852528834091,"['SLC6A1', 'AGT']",0.9999803516166453,0,0,2
329,Prostaglandin Synthesis and Regulation WP98,0.7438267948092205,0.7625865324103209,0.2256852528834091,"['PTGFR', 'PTGDS']",0.9999803516166453,0,0,2
330,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7438267948092205,0.7625865324103209,0.2256852528834091,"['PTGES2', 'HRAS']",0.9999803516166453,0,0,2
331,SARS-CoV-2 mitochondrial interactions WP5038,0.7438267948092205,0.7625865324103209,0.2256852528834091,"['NDUFB9', 'PHB']",0.9999803516166453,0,0,2
332,Myometrial relaxation and contraction pathways WP289,0.7439561220238323,0.8601255971230745,0.25440211889556225,"['RYR1', 'JUN', 'PRKCH', 'IGFBP5', 'RGS16', 'PRKCD', 'ACTG1', 'RGS2', 'PRKAR1A', 'GNG4', 'CRH', 'CALM3', 'PRKD1', 'ATF5', 'CORIN']",0.9999803516166453,0,0,15
333,Estrogen Receptor Pathway WP2881,0.7468295386265369,0.7627171947480148,0.22265111793054676,['JUN'],0.9999803516166453,0,0,1
334,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.7468295386265369,0.7627171947480148,0.22265111793054676,['ELOB'],0.9999803516166453,0,0,1
335,ID signaling pathway WP53,0.7468295386265369,0.7627171947480148,0.22265111793054676,['ID2'],0.9999803516166453,0,0,1
336,Mitochondrial CII Assembly WP4920,0.7468295386265369,0.7627171947480148,0.22265111793054676,['SDHAF1'],0.9999803516166453,0,0,1
337,NLR Proteins WP288,0.7468295386265369,0.7627171947480148,0.22265111793054676,['EPHB2'],0.9999803516166453,0,0,1
338,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.7468295386265369,0.7627171947480148,0.22265111793054676,['RNASEH2C'],0.9999803516166453,0,0,1
339,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7468295386265369,0.7627171947480148,0.22265111793054676,['TGFB1'],0.9999803516166453,0,0,1
340,Lipid Metabolism Pathway WP3965,0.753732670806703,0.7624557260920898,0.21555959339568753,"['LIPE', 'PRKAR1A', 'FASN']",0.9999803516166453,0,0,3
341,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.753732670806703,0.7624557260920898,0.21555959339568753,"['CALM3', 'AGT', 'CAMK1G']",0.9999803516166453,0,0,3
342,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7541353548795339,0.8003311258278145,0.22584016727955702,"['JUN', 'CDKN1B', 'TMSB4X', 'FN1', 'MYLK', 'PFN2']",0.9999803516166453,0,0,6
343,Calcium Regulation in the Cardiac Cell WP536,0.756767930874747,0.8508868198392749,0.23714099674264658,"['RYR1', 'PRKCH', 'RGS16', 'CHRM5', 'PRKCD', 'ADRA1D', 'ATP1B2', 'ATP1B1', 'GJD2', 'RGS2', 'PRKAR1A', 'GNG4', 'CALM3', 'PRKD1', 'CALR']",0.9999803516166453,0,0,15
344,Wnt signaling WP428,0.7658418313395071,0.8136436461759001,0.2170635403539878,"['SFRP4', 'SFRP1', 'PORCN', 'JUN', 'WNT5B', 'TCF7', 'ROR2', 'CXXC4', 'DKK2']",0.9999803516166453,0,0,9
345,MECP2 and Associated Rett Syndrome WP3584,0.7669977402045328,0.8051704367768164,0.21358870824398676,"['DLX5', 'SST', 'GAD1', 'RPS6', 'OPRK1', 'IGF1', 'SGK1', 'FKBP5']",0.9999803516166453,0,0,8
346,NAD+ biosynthetic pathways WP3645,0.7741590843625425,0.7116740088105726,0.18217281196856022,"['NMNAT1', 'ACMSD']",0.9999803516166453,0,0,2
347,Oxidative Stress WP408,0.7741590843625425,0.7116740088105726,0.18217281196856022,"['JUNB', 'TXN2']",0.9999803516166453,0,0,2
348,Purine metabolism and related disorders WP4224,0.7741590843625425,0.7116740088105726,0.18217281196856022,"['PRPS1', 'APRT']",0.9999803516166453,0,0,2
349,Regulation of Microtubule Cytoskeleton WP2038,0.7782959969979483,0.7621936805610275,0.1910426023563231,"['SPRED1', 'PARD6A', 'CFL2', 'TESK2', 'EPHB2']",0.9999803516166453,0,0,5
350,Melatonin metabolism and effects WP3298,0.7785544259432556,0.7277235161532682,0.1821611153723067,"['PER2', 'APOE', 'FOXO1']",0.9999803516166453,0,0,3
351,Nuclear receptors WP170,0.7785544259432556,0.7277235161532682,0.1821611153723067,"['NR2E1', 'NR2F2', 'RXRG']",0.9999803516166453,0,0,3
352,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.7785544259432556,0.7277235161532682,0.1821611153723067,"['CDKN1B', 'HRAS', 'FOXO1']",0.9999803516166453,0,0,3
353,15q11.2 copy number variation syndrome WP4940,0.7867897281447435,0.6673087506879471,0.16001679991011308,['TUBGCP4'],0.9999803516166453,0,0,1
354,Biotin Metabolism (including IEMs) WP5031,0.7867897281447435,0.6673087506879471,0.16001679991011308,['ACACB'],0.9999803516166453,0,0,1
355,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.7867897281447435,0.6673087506879471,0.16001679991011308,['GABBR1'],0.9999803516166453,0,0,1
356,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.7867897281447435,0.6673087506879471,0.16001679991011308,['JUN'],0.9999803516166453,0,0,1
357,Non-homologous end joining WP438,0.7867897281447435,0.6673087506879471,0.16001679991011308,['DCLRE1C'],0.9999803516166453,0,0,1
358,RAS and bradykinin pathways in COVID-19 WP4969,0.7867897281447435,0.6673087506879471,0.16001679991011308,['AGT'],0.9999803516166453,0,0,1
359,TCA cycle in senescence WP5050,0.7867897281447435,0.6673087506879471,0.16001679991011308,['GOT1'],0.9999803516166453,0,0,1
360,DNA damage response (only ATM dependent) WP710,0.7935748958037947,0.7958823140932506,0.18401384618412556,"['JUN', 'TGFB1', 'CDKN1B', 'WNT5B', 'CDKN2A', 'TCF7', 'BAX', 'HRAS', 'LDLR', 'BBC3']",0.9999803516166453,0,0,10
361,Pancreatic adenocarcinoma pathway WP4263,0.7952374608031236,0.7868036864856047,0.18026814588973994,"['TGFB1', 'CDK6', 'CDKN2A', 'GADD45A', 'PRKCD', 'BAX', 'PLD1', 'VEGFA', 'GADD45G']",0.9999803516166453,0,0,9
362,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7967903839140243,0.7409450266593124,0.1683157701594465,"['EIF4A2', 'RPS6KA5', 'PRKCD', 'RPS6', 'PIM1']",0.9999803516166453,0,0,5
363,Alpha 6 Beta 4 signaling pathway WP244,0.8012767854486147,0.6960114983830399,0.15420054129679964,"['PRKCD', 'GAB1', 'HRAS']",0.9999803516166453,0,0,3
364,Nanoparticle-mediated activation of receptor signaling WP2643,0.8012767854486147,0.6960114983830399,0.15420054129679964,"['ITGA1', 'FN1', 'HRAS']",0.9999803516166453,0,0,3
365,1q21.1 copy number variation syndrome WP4905,0.8013018842235662,0.6671255506607929,0.1477799966721288,"['FMO5', 'TJP2']",0.9999803516166453,0,0,2
366,Fluoropyrimidine Activity WP1601,0.8013018842235662,0.6671255506607929,0.1477799966721288,"['DPYD', 'GGH']",0.9999803516166453,0,0,2
367,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8013018842235662,0.6671255506607929,0.1477799966721288,"['GOT1', 'MDH2']",0.9999803516166453,0,0,2
368,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8013018842235662,0.6671255506607929,0.1477799966721288,"['HTR2C', 'HRAS']",0.9999803516166453,0,0,2
369,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.8013018842235662,0.6671255506607929,0.1477799966721288,"['MDH2', 'IDH3B']",0.9999803516166453,0,0,2
370,Trans-sulfuration and one-carbon metabolism WP2525,0.8013018842235662,0.6671255506607929,0.1477799966721288,"['AHCY', 'GSS']",0.9999803516166453,0,0,2
371,Tryptophan metabolism WP465,0.8013018842235662,0.6671255506607929,0.1477799966721288,"['DHCR24', 'ACMSD']",0.9999803516166453,0,0,2
372,Focal Adhesion WP306,0.8052223712911156,0.8268965517241379,0.1791362246176935,"['JUN', 'SHC3', 'HGF', 'ITGA2B', 'ITGA1', 'FN1', 'VEGFB', 'TESK2', 'IGF1', 'THBS4', 'MYLK', 'VEGFA', 'ACTG1', 'RELN', 'COL5A3', 'PDGFC', 'COL5A2', 'HRAS']",0.9999803516166453,0,0,18
373,7q11.23 copy number variation syndrome WP4932,0.8066974101271195,0.7840968245705362,0.16842920235878867,"['PCNA', 'ATP5MC2', 'EIF4H', 'ATP5MC3', 'UBE2L6', 'GTF2IRD1', 'ACACB', 'ATP5F1E', 'USF1', 'ATP5MC1']",0.9999803516166453,0,0,10
374,Cytosolic DNA-sensing pathway WP4655,0.8067085801764882,0.7113561190738699,0.1527941661772704,"['POLR1C', 'POLR2E', 'POLR2K', 'POLR2L']",0.9999803516166453,0,0,4
375,Glycogen Synthesis and Degradation WP500,0.8067085801764882,0.7113561190738699,0.1527941661772704,"['PHKG1', 'PPP2R5B', 'CALM3', 'GYG1']",0.9999803516166453,0,0,4
376,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.8204455152119292,0.5931021830856723,0.1173795334198553,['RUNX2'],0.9999803516166453,0,0,1
377,Canonical and non-canonical TGF-B signaling WP3874,0.8204455152119292,0.5931021830856723,0.1173795334198553,['TGFB1'],0.9999803516166453,0,0,1
378,Ganglio Sphingolipid Metabolism WP1423,0.8204455152119292,0.5931021830856723,0.1173795334198553,['B3GALT1'],0.9999803516166453,0,0,1
379,Hedgehog Signaling Pathway Netpath WP47,0.8204455152119292,0.5931021830856723,0.1173795334198553,['GLI3'],0.9999803516166453,0,0,1
380,"NAD metabolism, sirtuins and aging WP3630",0.8204455152119292,0.5931021830856723,0.1173795334198553,['FOXO1'],0.9999803516166453,0,0,1
381,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8220076403924281,0.6669421487603305,0.1307243887552883,"['PRKCH', 'PRKCD', 'HRAS']",0.9999803516166453,0,0,3
382,miRNA regulation of prostate cancer signaling pathways WP3981,0.8220076403924281,0.6669421487603305,0.1307243887552883,"['CDKN1B', 'TCF7', 'FOXO1']",0.9999803516166453,0,0,3
383,Neural Crest Cell Migration during Development WP4564,0.8220076403924281,0.6669421487603305,0.1307243887552883,"['JUN', 'EPHB2', 'EPHB3']",0.9999803516166453,0,0,3
384,Prion disease pathway WP3995,0.8220076403924281,0.6669421487603305,0.1307243887552883,"['PRNP', 'HSPA5', 'RFX5']",0.9999803516166453,0,0,3
385,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8220229065479807,0.7272727272727273,0.14253601270366448,"['ANGPT2', 'FN1', 'BAX', 'HRAS', 'ANGPTL1', 'FOXO1']",0.9999803516166453,0,0,6
386,Wnt signaling pathway and pluripotency WP399,0.8253505106495733,0.7483570805466705,0.1436449874516667,"['JUN', 'PRKCH', 'WNT5B', 'PRKCD', 'TCF7', 'ZBTB33', 'PRKD1', 'LDLR']",0.9999803516166453,0,0,8
387,Glycerolipids and Glycerophospholipids WP4722,0.8255061356723739,0.6278180875874579,0.12038950684221732,"['PLD1', 'CDIPT']",0.9999803516166453,0,0,2
388,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8255061356723739,0.6278180875874579,0.12038950684221732,"['GNA14', 'TRPC3']",0.9999803516166453,0,0,2
389,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.8362179400152635,0.7784058016122506,0.13923033683921132,"['DLX2', 'JUN', 'CEBPB', 'VIPR2', 'SLC1A3', 'ATP1A3', 'AQP4', 'ASCL1', 'VEGFA', 'PRKAR1A', 'SST', 'PAH', 'TAC1']",0.9999803516166453,0,0,13
390,B Cell Receptor Signaling Pathway WP23,0.8380094985157993,0.7353781672699562,0.12996032713751543,"['JUN', 'CD81', 'PRKCD', 'GAB1', 'ETS1', 'ILF2', 'HRAS', 'FOXO1']",0.9999803516166453,0,0,8
391,Kit receptor signaling pathway WP304,0.845028047388676,0.6837371123085408,0.11513138817505189,"['RPS6', 'KIT', 'JUNB', 'HRAS', 'SH2B2']",0.9999803516166453,0,0,5
392,Sphingolipid Metabolism (general overview) WP4725,0.8470230054171837,0.5928781204111601,0.0984340268642061,"['CERS4', 'SMPD1']",0.9999803516166453,0,0,2
393,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.8487910642036226,0.5337369290038525,0.08750201666424165,['RPH3AL'],0.9999803516166453,0,0,1
394,Leptin Insulin Overlap WP3935,0.8487910642036226,0.5337369290038525,0.08750201666424165,['LEPR'],0.9999803516166453,0,0,1
395,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.8487910642036226,0.5337369290038525,0.08750201666424165,['SFRP4'],0.9999803516166453,0,0,1
396,Ebola Virus Pathway on Host WP4217,0.8529912595287762,0.7402286135693216,0.11770077485536519,"['ITGA1', 'VPS4A', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'MFGE8', 'MERTK', 'ASGR1', 'ACTG1']",0.9999803516166453,0,0,10
397,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8579634898752697,0.6155117609663064,0.09429254436320832,"['JUN', 'TGFB1', 'VEGFA']",0.9999803516166453,0,0,3
398,IL-5 signaling pathway WP127,0.8579634898752697,0.6155117609663064,0.09429254436320832,"['SPRED1', 'JUN', 'RPS6']",0.9999803516166453,0,0,3
399,AGE/RAGE pathway WP2324,0.8588440540585485,0.6665747380033095,0.10143128945089015,"['JUN', 'PRKCD', 'CYCS', 'TIRAP', 'FOXO1']",0.9999803516166453,0,0,5
400,Sphingolipid Metabolism (integrated pathway) WP4726,0.8660975744613636,0.5616160445165778,0.0807366331895705,"['CERS4', 'SMPD1']",0.9999803516166453,0,0,2
401,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.8726638388328575,0.48516535748236356,0.06608188038691351,['ABCB1'],0.9999803516166453,0,0,1
402,Omega-3/Omega-6 FA synthesis WP4723,0.8726638388328575,0.48516535748236356,0.06608188038691351,['ACOT2'],0.9999803516166453,0,0,1
403,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.8726638388328575,0.48516535748236356,0.06608188038691351,['LDHA'],0.9999803516166453,0,0,1
404,Amyotrophic lateral sclerosis (ALS) WP2447,0.8734310700626582,0.5926538108356291,0.08020150805138351,"['CCS', 'TOMM40', 'BAX']",0.9999803516166453,0,0,3
405,Neural Crest Cell Migration in Cancer WP4565,0.8734310700626582,0.5926538108356291,0.08020150805138351,"['JUN', 'EPHB2', 'EPHB3']",0.9999803516166453,0,0,3
406,MET in type 1 papillary renal cell carcinoma WP4205,0.874119812376812,0.6663907284768212,0.0896547609570987,"['JUN', 'HGF', 'RPL11', 'GAB1', 'ETS1', 'HRAS']",0.9999803516166453,0,0,6
407,G Protein Signaling Pathways WP35,0.8766261724393323,0.7052970441908106,0.09286973063408906,"['GNA14', 'PRKCH', 'PRKD3', 'PRKAR1A', 'GNG4', 'PDE1A', 'PRKCD', 'PRKD1', 'HRAS']",0.9999803516166453,0,0,9
408,Amino Acid metabolism WP3925,0.8775722630308322,0.6783896390743437,0.08859495702353327,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'GSS', 'ODC1', 'SRM']",0.9999803516166453,0,0,7
409,DNA IR-damage and cellular response via ATR WP4016,0.8775722630308322,0.6783896390743437,0.08859495702353327,"['FANCI', 'SEM1', 'BRIP1', 'PCNA', 'POLN', 'ABRAXAS1', 'USP1']",0.9999803516166453,0,0,7
410,MTHFR deficiency WP4288,0.8829645102292965,0.5334801762114537,0.06640242234714586,"['CHDH', 'CYCS']",0.9999803516166453,0,0,2
411,ATM Signaling Network in Development and Disease  WP3878,0.8836896372884977,0.6094188061111986,0.07535424963234048,"['DCLRE1C', 'KAT5', 'HMGN1', 'CDK5R1']",0.9999803516166453,0,0,4
412,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8849437821044778,0.652723340992026,0.0797831305003953,"['JUN', 'CDKN1B', 'APEX1', 'RPS6', 'PLD1', 'HRAS']",0.9999803516166453,0,0,6
413,Vitamin D-sensitive calcium signaling in depression WP4698,0.887387004122042,0.5714285714285714,0.06827090573569361,"['GPX4', 'ATP2B4', 'PVALB']",0.9999803516166453,0,0,3
414,Apoptosis Modulation by HSP70 WP384,0.8927692901635121,0.44468904788112273,0.05043978250594456,['CYCS'],0.9999803516166453,0,0,1
415,MAPK pathway in congenital thyroid cancer WP4928,0.8927692901635121,0.44468904788112273,0.05043978250594456,['JUN'],0.9999803516166453,0,0,1
416,NAD+ metabolism WP3644,0.8927692901635121,0.44468904788112273,0.05043978250594456,['NMNAT1'],0.9999803516166453,0,0,1
417,Nicotine Activity on Dopaminergic Neurons WP1602,0.8927692901635121,0.44468904788112273,0.05043978250594456,['CHRNA6'],0.9999803516166453,0,0,1
418,Integrated breast cancer pathway WP1984,0.893653471804757,0.7308595278466153,0.08217579479829715,"['JUN', 'GADD45A', 'DCAKD', 'ODC1', 'PHB', 'HMGCR', 'JAKMIP1', 'BACH1', 'FOXO1', 'VEGFA', 'BAX', 'FILIP1', 'FAU', 'RPP38']",0.9999803516166453,0,0,14
419,3q29 copy number variation syndrome WP4906,0.8942293776843453,0.6198771148937262,0.06929789882887198,"['JUN', 'TGFB1', 'NCBP2', 'WDR34', 'DYNLL2']",0.9999803516166453,0,0,5
420,Rett syndrome causing genes WP4312,0.8942293776843453,0.6198771148937262,0.06929789882887198,"['KCNJ10', 'SATB2', 'IMPDH2', 'HAP1', 'GABRD']",0.9999803516166453,0,0,5
421,IL17 signaling pathway WP2112,0.8978452538492435,0.5080239144115796,0.05474341166597343,"['CEBPB', 'TRAF3IP2']",0.9999803516166453,0,0,2
422,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8978452538492435,0.5080239144115796,0.05474341166597343,"['TGFB1', 'BAX']",0.9999803516166453,0,0,2
423,Sphingolipid pathway WP1422,0.8978452538492435,0.5080239144115796,0.05474341166597343,"['CERS4', 'SERINC1']",0.9999803516166453,0,0,2
424,22q11.2 copy number variation syndrome WP4657,0.899378199503377,0.6660220994475138,0.07063273850189716,"['RANBP1', 'MRPL40', 'RELN', 'THAP7', 'RCC1', 'DGCR6L', 'FGFR2', 'RAN']",0.9999803516166453,0,0,8
425,Leptin signaling pathway WP2034,0.9054635806703373,0.6431005921666445,0.06386517676086548,"['CFL2', 'RPS6', 'LEPR', 'BAX', 'HRAS', 'ACACB', 'FOXO1']",0.9999803516166453,0,0,7
426,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9060604808988675,0.5763580559611431,0.056857272204935895,"['ADCY10', 'TGFB1', 'BANF1', 'HRAS']",0.9999803516166453,0,0,4
427,Signal transduction through IL1R WP4496,0.9109463536039765,0.48488185822987584,0.045225547118665076,"['JUN', 'TGFB1']",0.9999803516166453,0,0,2
428,IL-3 signaling pathway WP286,0.9112342250947154,0.5332231404958677,0.04956592077262382,"['JUN', 'TGFB1', 'HRAS']",0.9999803516166453,0,0,3
429,Ectoderm Differentiation WP2858,0.9182594672597124,0.6869574536491265,0.058580492109859904,"['PPFIBP2', 'MAFB', 'HDAC10', 'PIM1', 'SPRY2', 'ROR2', 'NR2F2', 'ARHGAP15', 'JAKMIP1', 'PTPN13', 'FGFR2', 'GLI3']",0.9999803516166453,0,0,12
430,Alzheimer's disease WP2059,0.9206773299162292,0.6032112957640885,0.04985279062242085,"['ATP5MD', 'PSEN2', 'CYCS', 'CALM3', 'APOE', 'CDK5R1']",0.9999803516166453,0,0,6
431,TGF-beta Signaling Pathway WP366,0.9214997646729104,0.6731866496192966,0.05503486474773323,"['TGFBR3', 'JUN', 'TGFB1', 'PARD6A', 'SUMO1', 'FN1', 'STRAP', 'NEDD9', 'ETS1', 'JUNB', 'RUNX2']",0.9999803516166453,0,0,11
432,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9216708759703236,0.5792704861027842,0.04724940593247732,"['SGCD', 'ITGA2B', 'ITGA1', 'TCF7', 'ACTG1']",0.9999803516166453,0,0,5
433,Ebstein-Barr virus LMP1 signaling WP262,0.9239614867651021,0.3810834185077443,0.03013793992836731,['HSP90AA1'],0.9999803516166453,0,0,1
434,16p11.2 proximal deletion syndrome WP4949,0.9279293941827899,0.5919793966151582,0.04427984157794196,"['PCNA', 'ASPHD1', 'KCTD13', 'SEZ6L2', 'CCT7', 'CDIPT']",0.9999803516166453,0,0,6
435,PDGF Pathway WP2526,0.9303997027364078,0.4997933884297521,0.03605559347456545,"['JUN', 'ARFIP2', 'HRAS']",0.9999803516166453,0,0,3
436,Cardiac Hypertrophic Response WP2795,0.9324787314329415,0.5329658213891951,0.037259073411921695,"['TGFB1', 'PRKD1', 'IGF1', 'FGFR2']",0.9999803516166453,0,0,4
437,Intraflagellar transport proteins binding to dynein WP4532,0.9325570969058631,0.44438325991189426,0.031029016424072756,"['WDR34', 'DYNLL2']",0.9999803516166453,0,0,2
438,PDGFR-beta pathway WP3972,0.9325570969058631,0.44438325991189426,0.031029016424072756,"['JUN', 'HRAS']",0.9999803516166453,0,0,2
439,Immune response to tuberculosis WP4197,0.9359704070015291,0.35564116675839297,0.023533280821288912,['IFIT3'],0.9999803516166453,0,0,1
440,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.9359704070015291,0.35564116675839297,0.023533280821288912,['CEBPB'],0.9999803516166453,0,0,1
441,Circadian rhythm related genes WP3594,0.9406842881502457,0.6819830197534025,0.04170169476075277,"['JUN', 'AHCY', 'BHLHE41', 'RBM4B', 'HCRTR2', 'CIART', 'PER2', 'HTR7', 'DBP', 'NFIL3', 'ID2', 'CRH', 'PTGDS', 'ATF5', 'RPS27A']",0.9999803516166453,0,0,15
442,Insulin Signaling WP481,0.9406842881502457,0.6819830197534025,0.04170169476075277,"['XBP1', 'JUN', 'PRKCH', 'SHC3', 'PRKCD', 'GAB1', 'FOXO1', 'LIPE', 'RPS6KA5', 'SGK1', 'GYG1', 'HRAS', 'PFKM', 'SH2B2', 'ARF6']",0.9999803516166453,0,0,15
443,Hepatitis B infection WP4666,0.9424628211362988,0.6433284479770368,0.038122876663263645,"['JUN', 'TICAM2', 'TGFB1', 'PCNA', 'ATP6AP1', 'VDAC3', 'CYCS', 'PTK2B', 'BAX', 'HRAS', 'TIRAP']",0.9999803516166453,0,0,11
444,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9460835567719003,0.3333791964777105,0.018477337747832133,['H3F3B'],0.9999803516166453,0,0,1
445,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.9460835567719003,0.3333791964777105,0.018477337747832133,['HRAS'],0.9999803516166453,0,0,1
446,TLR4 Signaling and Tolerance WP3851,0.9460835567719003,0.3333791964777105,0.018477337747832133,['TIRAP'],0.9999803516166453,0,0,1
447,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9462942082289786,0.5606483095155106,0.030948771141780792,"['TGFB1', 'IGF1', 'IL6ST', 'AGT', 'FGFR2', 'MYLK']",0.9999803516166453,0,0,6
448,Regulation of Actin Cytoskeleton WP51,0.948009299106698,0.6449209705023659,0.034432954634812246,"['FGF9', 'CFL2', 'TMSB4X', 'CHRM5', 'F2R', 'ITGA1', 'FN1', 'FGF1', 'FGFR3', 'FGFR2', 'MYLK', 'ACTG1']",0.9999803516166453,0,0,12
449,ATM Signaling Pathway WP2516,0.9491346597069306,0.41011521518129446,0.02140989830749152,"['JUN', 'GADD45A']",0.9999803516166453,0,0,2
450,Splicing factor NOVA regulated synaptic proteins WP4148,0.9521027598708459,0.4568122786304604,0.022421401403397264,"['NTNG1', 'EPB41', 'APLP2']",0.9999803516166453,0,0,3
451,16p11.2 distal deletion syndrome WP4950,0.9546000692394587,0.31373628152416716,0.014577066690370328,['CD81'],0.9999803516166453,0,0,1
452,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9546000692394587,0.31373628152416716,0.014577066690370328,['MAP1LC3A'],0.9999803516166453,0,0,1
453,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9546000692394587,0.31373628152416716,0.014577066690370328,['FOXO1'],0.9999803516166453,0,0,1
454,Vitamin D in inflammatory diseases WP4482,0.9546000692394587,0.31373628152416716,0.014577066690370328,['DUSP1'],0.9999803516166453,0,0,1
455,Wnt signaling in kidney disease WP4150,0.9546000692394587,0.31373628152416716,0.014577066690370328,['WNT5B'],0.9999803516166453,0,0,1
456,CAMKK2  Pathway WP4874,0.9558880386446662,0.39488497307880566,0.017815033054585056,"['FIS1', 'MAP1LC3A']",0.9999803516166453,0,0,2
457,Hedgehog Signaling Pathway WP4249,0.9558880386446662,0.39488497307880566,0.017815033054585056,"['HHIP', 'GLI3']",0.9999803516166453,0,0,2
458,Pathways affected in adenoid cystic carcinoma WP3651,0.9572310134209903,0.4843139220206475,0.021169614985346818,"['MYCBP', 'CNTN6', 'HRAS', 'FOXP2']",0.9999803516166453,0,0,4
459,IL-4 signaling pathway WP395,0.9578038201078987,0.4440771349862259,0.01914518784897469,"['CEBPB', 'HRH1', 'NFIL3']",0.9999803516166453,0,0,3
460,Corticotropin-releasing hormone signaling pathway WP2355,0.9603447267877985,0.5324503311258278,0.021544521015468276,"['CRHBP', 'HSP90AA1', 'TGFB1', 'PRKCD', 'CRH', 'JUNB']",0.9999803516166453,0,0,6
461,MAPK Cascade WP422,0.9617777818362853,0.38074260541220895,0.014838244092158072,"['JUN', 'HRAS']",0.9999803516166453,0,0,2
462,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9627550304310808,0.6284260891463107,0.023852717375693902,"['LINGO1', 'JUN', 'RAB3A', 'SHC3', 'RPS6', 'PRKCD', 'FRS3', 'ACACB', 'RPS6KA5', 'PTK2B', 'HRAS', 'SH2B2', 'CDK5R1']",0.9999803516166453,0,0,13
463,mRNA Processing WP411,0.9627550304310808,0.6284260891463107,0.023852717375693902,"['SF3B5', 'SF3A1', 'CPSF1', 'NCBP2', 'SNU13', 'LSM2', 'PRPF4', 'LSM7', 'SNRPD1', 'CD2BP2', 'SNRPE', 'SNRPA1', 'SRSF9']",0.9999803516166453,0,0,13
464,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.962863555740738,0.43203037748492296,0.01634956919208702,"['MAP1LC3A', 'GTPBP2', 'FTL']",0.9999803516166453,0,0,3
465,Netrin-UNC5B signaling pathway WP4747,0.9669081409275149,0.3675755734467568,0.012369573033532165,"['JUN', 'PTK2B']",0.9999803516166453,0,0,2
466,Notch Signaling WP268,0.9669081409275149,0.3675755734467568,0.012369573033532165,"['MAML1', 'PSEN2']",0.9999803516166453,0,0,2
467,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9669081409275149,0.3675755734467568,0.012369573033532165,"['TGFB1', 'IFIT2']",0.9999803516166453,0,0,2
468,Estrogen signaling pathway WP712,0.9678112614836379,0.2806534773918837,0.00918247338276433,['JUN'],0.9999803516166453,0,0,1
469,NO/cGMP/PKG mediated Neuroprotection WP4008,0.9713719869544357,0.3552863436123348,0.010319571564724898,"['PDE3A', 'CYCS']",0.9999803516166453,0,0,2
470,Cannabinoid receptor signaling WP3869,0.9728968939441724,0.2665932856356632,0.007325228918420608,['PRKAR1A'],0.9999803516166453,0,0,1
471,Nanoparticle triggered autophagic cell death WP2509,0.9728968939441724,0.2665932856356632,0.007325228918420608,['MAP1LC3A'],0.9999803516166453,0,0,1
472,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9732229466787939,0.4753368528878733,0.012901635530109538,"['SLCO1C1', 'NPY', 'RPS6', 'HRAS', 'FOXO1']",0.9999803516166453,0,0,5
473,G13 Signaling Pathway WP524,0.9752518049182164,0.34378996731561745,0.008615232145639097,"['CFL2', 'IQGAP2']",0.9999803516166453,0,0,2
474,Endoderm differentiation WP2853,0.9777963514128055,0.5438715513342379,0.01221201581814951,"['DUSP4', 'SFRP1', 'TGFB1', 'TCEAL2', 'TCF7', 'SLC2A12', 'PBX3', 'FOXO1', 'PTHLH']",0.9999803516166453,0,0,9
475,Notch Signaling Pathway Netpath WP61,0.9779250395541419,0.38971981455351745,0.00869942646543778,"['MAML2', 'MAML1', 'PSEN2']",0.9999803516166453,0,0,3
476,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9838218165740092,0.23174846258763848,0.003779928442618376,['JUN'],0.9999803516166453,0,0,1
477,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9840760619932801,0.3133583830007774,0.00503005575775433,"['JUN', 'LCP2']",0.9999803516166453,0,0,2
478,EGF/EGFR signaling pathway WP437,0.9849347465597037,0.5706416977633296,0.008662276576270922,"['NDUFA13', 'JUN', 'PCNA', 'PRKCD', 'GAB1', 'NEDD8', 'PLD1', 'FOXO1', 'RPS6KA5', 'PTK2B', 'SPRY2', 'HRAS', 'ARF6']",0.9999803516166453,0,0,13
479,Ras signaling WP4223,0.9849347465597037,0.5706416977633296,0.008662276576270922,"['SHC3', 'RASGRF2', 'GAB1', 'PLD1', 'ETS1', 'HTR7', 'GNG4', 'KIT', 'CALM3', 'FGFR3', 'HRAS', 'FGFR2', 'ARF6']",0.9999803516166453,0,0,13
480,Glycerophospholipid Biosynthetic Pathway WP2533,0.9863785693905373,0.2220693450742983,0.00304569293779466,['CDIPT'],0.9999803516166453,0,0,1
481,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9863785693905373,0.2220693450742983,0.00304569293779466,['RPS6'],0.9999803516166453,0,0,1
482,ErbB signaling pathway WP673,0.9863857641937355,0.45591296121097447,0.006249545142571229,"['JUN', 'CDKN1B', 'SHC3', 'GAB1', 'HRAS', 'FOXO1']",0.9999803516166453,0,0,6
483,Male infertility WP4673,0.9865479851744576,0.42906962261800974,0.00581102413919151,"['ABCB1', 'MSH4', 'PEX10', 'TEX15', 'ETV5']",0.9999803516166453,0,0,5
484,TNF-alpha signaling pathway WP231,0.9865479851744576,0.42906962261800974,0.00581102413919151,"['HSP90AA1', 'JUN', 'RFK', 'BAX', 'HRAS']",0.9999803516166453,0,0,5
485,RANKL/RANK signaling pathway WP2018,0.9881677378346898,0.2958883994126285,0.003521906508640776,"['JUN', 'PAPSS2']",0.9999803516166453,0,0,2
486,Fatty acid beta-oxidation WP143,0.9885313840738214,0.21316455696202533,0.002458829223184319,['LIPE'],0.9999803516166453,0,0,1
487,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.989151647121413,0.465184980673661,0.00507406347401091,"['NRP2', 'TGFB1', 'WNT5B', 'ID2', 'FN1', 'STRAP', 'HRAS']",0.9999803516166453,0,0,7
488,Histone Modifications WP2369,0.9898089981701452,0.28786165019645193,0.0029486490986605843,"['SET', 'H3F3B']",0.9999803516166453,0,0,2
489,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9901230098943938,0.33975734130473007,0.003372462339900362,"['GHR', 'F2R', 'IL6ST']",0.9999803516166453,0,0,3
490,Toll-like Receptor Signaling Pathway WP75,0.9901230098943938,0.33975734130473007,0.003372462339900362,"['JUN', 'TICAM2', 'TIRAP']",0.9999803516166453,0,0,3
491,Regulation of toll-like receptor signaling pathway WP1449,0.9905647009447848,0.4091391234248377,0.0038786771355180344,"['JUN', 'CUEDC2', 'TICAM2', 'PELI3', 'TIRAP']",0.9999803516166453,0,0,5
492,Autophagy WP4923,0.9918702801391981,0.19733382254020668,0.001610825384057129,['MAP1LC3B'],0.9999803516166453,0,0,1
493,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9918702801391981,0.19733382254020668,0.001610825384057129,['SUPT4H1'],0.9999803516166453,0,0,1
494,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9918702801391981,0.19733382254020668,0.001610825384057129,['JUN'],0.9999803516166453,0,0,1
495,Phosphoinositides metabolism WP4971,0.9931553200814374,0.1902665303876091,0.0013067909018676296,['PIP4P1'],0.9999803516166453,0,0,1
496,Ciliopathies WP4803,0.9932035837658747,0.5306371191135734,0.003618741946092855,"['DNAAF1', 'DNAAF4', 'WDR34', 'CCDC28B', 'GLI3', 'TMEM237', 'MAK', 'NME9', 'HYDIN', 'CCDC65', 'CCNQ', 'DNAI1', 'TRIM32']",0.9999803516166453,0,0,13
497,Wnt Signaling Pathway WP363,0.9944196609562969,0.259670140754271,0.0014531056173303855,"['CDK6', 'ROR2']",0.9999803516166453,0,0,2
498,Ciliary landscape WP4352,0.9948265404227067,0.5644378698224852,0.002927676157355048,"['DOCK5', 'EXOC8', 'VPS4A', 'HTRA2', 'COPS7A', 'MYL6B', 'IQGAP2', 'WDR34', 'COX6C', 'DYNLL2', 'LSM4', 'PSMD8', 'GID8', 'CD2BP2', 'MCM6', 'VIM', 'COPS8', 'DCAF11']",0.9999803516166453,0,0,18
499,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9951481983771373,0.1775454045129334,0.0008635115732161203,['ACTG1'],0.9999803516166453,0,0,1
500,Interferon type I signaling pathways WP585,0.9952050903849048,0.25346129641283827,0.0012182470391339292,"['RPS6KA5', 'RPS6']",0.9999803516166453,0,0,2
501,Thermogenesis WP4321,0.9956627140154615,0.39850993377483446,0.0017322108187557868,"['LIPE', 'ADCY10', 'RPS6', 'ACTL6A', 'HRAS', 'ACTG1']",0.9999803516166453,0,0,6
502,Disruption of postsynaptic signaling by CNV WP4875,0.9959151363610497,0.1718003799243702,0.000703218380541366,['SHANK1'],0.9999803516166453,0,0,1
503,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9959151363610497,0.1718003799243702,0.000703218380541366,['GABRD'],0.9999803516166453,0,0,1
504,Prolactin Signaling Pathway WP2037,0.9962475667252452,0.29550045913682277,0.0011109314095783683,"['JUN', 'RPS6', 'HRAS']",0.9999803516166453,0,0,3
505,MAPK Signaling Pathway WP382,0.9972641767755955,0.5232046697085543,0.0014333570875591833,"['DUSP4', 'JUN', 'TGFB1', 'GADD45A', 'DUSP1', 'RASGRF2', 'PRKCD', 'FGF1', 'DUSP7', 'CACNA1G', 'RPS6KA5', 'FGF9', 'DDIT3', 'HRAS', 'FGFR3', 'FGFR2']",0.9999803516166453,0,0,16
506,Common Pathways Underlying Drug Addiction WP2636,0.9982717227168726,0.14786277747202348,0.00025576896288817004,['ACTG1'],0.9999803516166453,0,0,1
507,Fragile X Syndrome  WP4549,0.998319964726402,0.4042304656669298,0.0006796925547217719,"['PRKAR1A', 'CDKN2A', 'GAD1', 'GAB1', 'PPP2R5B', 'SLC6A1', 'GABRD', 'SHANK1']",0.9999803516166453,0,0,8
508,Integrin-mediated Cell Adhesion WP185,0.9984074945924589,0.30360686722318475,0.000483880971696195,"['SHC3', 'ITGA2B', 'ITGA1', 'HRAS']",0.9999803516166453,0,0,4
509,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9987746310882846,0.14005155982967876,0.00017172005916361226,['DDX3Y'],0.9999803516166453,0,0,1
510,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9988777730368114,0.3713749309773606,0.0004170009896608495,"['SLCO1C1', 'RPS6KA5', 'SHC3', 'SCD', 'FASN', 'HRAS', 'FOXO1']",0.9999803516166453,0,0,7
511,Joubert Syndrome WP4656,0.9989567747108522,0.2530499803227076,0.0002641259342850268,"['KAT5', 'TMEM237', 'PDE6B']",0.9999803516166453,0,0,3
512,Chemokine signaling pathway WP3929,0.9989822262939942,0.346098473941837,0.0003524293035437794,"['SHC3', 'GNG4', 'PRKCD', 'PTK2B', 'CXCL14', 'HRAS']",0.9999803516166453,0,0,6
513,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.999131009094664,0.13302146395156852,0.00011564469676380271,['RPS6KA5'],0.9999803516166453,0,0,1
514,Energy Metabolism WP1541,0.9992681184078428,0.12976361464220035,9.5006371838155e-05,['FOXO1'],0.9999803516166453,0,0,1
515,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.999480676596177,0.12370249964802703,6.425829004014253e-05,['HRAS'],0.9999803516166453,0,0,1
516,IL-1 signaling pathway WP195,0.9997379538483362,0.11312778838159697,2.9648586410302513e-05,['JUN'],0.9999803516166453,0,0,1
517,Mesodermal commitment pathway WP2857,0.999845166767669,0.24385051134851538,3.775908613377801e-05,"['PRKAR1A', 'SLC2A12', 'PBX3', 'RPL38']",0.9999803516166453,0,0,4
518,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999803516166453,0.17467986558895648,3.4322106822391364e-06,"['CDK20', 'TULP3', 'WDR34']",0.9999803516166453,0,0,3
